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Abstract
NorM multidrug transport proteins belong to the multiple antibiotics and toxins extrusion
(MATE) family of secondary active transporters. Members of this family are present across
all species including bacteria, plants and humans. In bacteria, their over-expression can lead
to antibiotic resistance, whereas in the human body, the transporters can alter the plasma
levels of drugs. NorM proteins are therefore relevant for the pharmacokinetic properties
of drugs. Previously, NorM from Vibrio cholerae (NorM-VC) was shown to export drug
(ethidium) in an antiport reaction that is coupled to the simultaneous uptake of protons and
sodium ions down their electrochemical gradients across the plasma membrane. But NorM
from Pseudomonas stutzeri (NorM-PS) was shown to transport DAPI by utilising proton
cycling exclusively. NorM-VC and NorM-PS share 42% identical amino-acid residues and
yet their functions differ in terms of their ion coupling properties. These differences in
functionality of two highly homologous proteins provide an excellent opportunity to carry
out a comparative study. The work presented in this thesis investigates the energetics of drug
transport processes by NorM-VC and NorM-PS and the structural basis for ion-coupled drug
transport by NorM-VC. Ethidium efflux assays in intact Lactococcus lactis cells were used to
study the effect of the magnitude and composition of the proton- and sodium-motive force on
transport activity. Furthermore, ethidium binding assays were used to study partial reactions
in drug efflux processes. These biochemical data were supplemented by computational
studies and analyses of current protein structures. Based on the observations detailed here,
a novel transport model for NorM-VC is proposed, which explains published findings for
NorM-VC and other MATE transporters. The model represents a potentially universal
mechanism for MATE transporters that can be used to predict further structure-function
relationships in this important family of member transporters.
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“Good fences make good neighbours.”
Robert Frost, Mending Wall
1.1 Drug-resistance: a global health problem
Drug-resistance poses one of the biggest threats to human health. In 2017, the World Health
Organisation published a list of 12 pathogenic bacteria that cannot be treated with currently
available antibiotics [1]. The list includes certain strains of stomach ulcer and cancer causing
Helicobacter pylori, pneumonia and meningitis causing Haemophilus influenza and several
other deadly pathogens. The threats posed by drug resistance on current drug therapies is
evident if one looks at the vanishing number of antimicrobial agents that have been developed
over the past few decades. As shown in Figure 1.1, no novel antibiotic class has emerged
from drug development projects since the 1980’s.
Fig. 1.1 A brief timeline of some of the major antibiotic discoveries followed by a discovery
void.
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Several factors are involved in the underlying mechanisms of drug resistance: the compo-
sition of cell walls [2], enzymatic modification or degradation of drug molecules [3], altered
sensitivity of the targets via mutations [4] or conformational alterations [5], and extrusion of
drug molecules [6]. The drug extrusion process is facilitated by the notoriously promiscuous
multidrug transporters (MDTs). MDTs are integral membrane proteins and act as gateways
for their substrates. These proteins, which perhaps evolved as housekeeping agents for the
disposal of cellular metabolic waste, later also served to protect cells from external harmful
chemicals. Such primordial function of transporter proteins is supported by their ubiquity.
As of 2016, the Transporter Classification DataBase (TCBD) contains more than 10,000
non-redundant transport systems [7].
The overexpression of MDTs has led to ever increasing cases of drug-resistant pathogens
[8] and chemotherapy-resistant tumour cells (overexpression of P-Glycoprotein [9] and/or
ABCG2 [10]). The importance of MDTs is further accentuated by the fact that they are
heavily expressed in human liver [11] and kidney [12] tissues where they affect drug pharma-
cokinetics and the redistribution of endogenous metabolites and xenobiotics. For example,
cimetidine, a H2-blocker used to prevent and treat gastric ulcers, interacts with other co-
administered drugs by competitively inhibiting a human multidrug transporter, hMATE1,
during the final secretion step of drugs in the kidney [13]. The implications of MDTs in
pharmacokinetics makes it crucial to consider drug-transporter interactions for developing
better novel drug candidates and for such information to be a part of drug toxicity guidelines.
1.2 Multidrug transporters: they come in all shapes and
sizes
On the basis of the energy dependence and phylogeny, MDTs, and solute transporters in
general, have been classified into six different superfamilies [14]. These are: the ATP-
binding cassette (ABC) superfamily, the major facilitator superfamily (MFS), the resis-
tance/nodulation/division (RND) superfamily, the small multidrug resistance (SMR) family,
the multidrug and toxic compound extrusion (MATE) family, and the recently added pro-
teobacterial antimicrobial compound efflux (PACE) family [15]. The following table lists a
few examples of each class of multidrug transporters together with their physiological and
clinical relevance.
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Table 1.1 Transporter proteins and their relevance
Family Member proteins Physiological/Clinical relevance
ABC MDR1 (ABCB1) Resistance to anticancer agents [16], [17]
BCRP (ABCG2) Gene mutation causes cystic fibrosis [18]
MFS RFC (SLC19A1) Folate transport, methotrexate resistance [19]
Glucose transporters Type-2 diabetes [20], implicated in cancer [21]
RND BepDE and BepFG Antibiotic resistance in Brucella suis [22]
SMR EmrE Antibiotic resistance [23]
MATE NorM, YdhE, DinF Antibiotic resistance [24]
Human MATE1 Drug-drug interactions & pharmacokinetics [12]
PACE AceI Resistance to biocides [15]
1.3 The energetics of transport
The transport process can either be passive or active. Passive transport occurs in the direction
of a concentration gradient of the substrate and requires no other energy source. In contrast,
the active transport of a substrate requires energy derived from biochemical reactions such
as ATP-hydrolysis, ion gradients or, in the case of a charged substrate, electrical potential
difference. With access to an energy source, cellular transport systems can transport a
substrate against its concentration gradient. The ion gradient dependent secondary active
transport is called symport or co-transport when both the driving ion and driven ion or
molecule move in the same direction, and antiport or exchange when the driving ion and
driven ion or molecule move in the opposite directions.
4 Introduction
The different modes of transport are summarised in Figure 1.2.
Fig. 1.2 Schematic of different membrane transport systems. Facilitated transporters allow
passage of drugs down their concentration gradient. Primary-active transporters, also known
as ABC transporters, utilise ATP-hydrolysis to transport drugs against their concentration
gradient. Another type of ATP-hydrolysing transporters can establish ion-gradients which in
turn can be utilised by ion-exchangers to establish ion-gradients of a different type, or by
secondary-active drug transporters to transport drugs against their concentration gradients.
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The separation of ions by transporters has two consequences: a) formation of a chemical
ion gradient and, b) an electrical potential difference. Collectively, these are known as
the electrochemical ion gradient. The interiors of metabolically active cells are alkaline
and negatively charged relative to the exterior, therefore the total energy conserved by a
membrane is the sum of the proton gradient (∆pH) and the electrical potential difference
(∆ψ).
For protons, the proton motive force = Electrical potential difference + proton gradient
The corresponding formula is: ∆p (in mV) = ∆ψ - 59.1×∆pH
The Gibbs energy change when 1 mole of a monocation X+ is transported down an
electric potential of ∆ψ mV from a concentration of [X+]A to [X+]B is given by:
∆ G(kJmol-) = -F∆ψ+2.3RTlog10([X+]A/[X+]B)
where R is the gas constant and T is the absolute temperature.
For protons: ∆µH+ = -F∆ψ - 2.3RT×∆pH
The term proton motive force (pmf or ∆p) is defined in units of voltage where:
∆p (mV) = -(∆µH+)/F
Hence: ∆p = ∆ ψ - 2.3RT× ∆pH
Substituting values for R and T at room temperature: ∆p = ∆ ψ - 59× ∆pH
The active export of Na+ across the membrane to the exterior of the cell generates the
equivalent sodium motive force (∆pNa). Hence, in principle, a secondary-active transport
system has two sources of energy: the first of which is the concentration gradient of ions,
and the second is the potential difference.
1.3.1 Bio-energetic consequences of different stoichiometries: is more
always better?
With the emergence of cells that maintain ion gradients and voltage difference across the mem-
brane, cellular transport systems might have adapted to utilise the components of such energy
reservoirs differently. An antiporter with 1:1 stoichiometry does not perturb the membrane
potential and hence there will be no build-up of a by-product. In contrast, an antiporter with a
different stoichiometry will lead to a build-up of a net charge that, depending on the nature of
charged species, would enhance or inhibit the transport. For positively charged species X and
Y, the schematic of electroneutral and electrogenic transports can be summarised as following:
Electroneutral: X +in /Y+out ↔ X +out/Y+in
Electrogenic: X+in /Y+out & Z+out ↔ X+out/Y+in & Z+in + ∆ψ
6 Introduction
For secondary active transporters, a net incoming positive charge should be favoured
due to the negative nature of the cytosol. Hence a transporter that imports more than one
cation while exporting one cationic drug should be more efficient than a transporter with a
simple 1:1 stoichiometry (discounting the osmotic effects). Furthermore, a transport system
with more than one incoming ion, will have more choice in terms of what type of ions can
be used. For instance, a system capable of importing one H+ and one Na+ at once should
be more successful as it would function in the absence of either ion gradient. These are
purely hypothetical speculations and the biochemical feasibility is a concern of a different
kind. It is, however, also important to consider that there is a distinction between binding
stoichiometry and transport stoichiometry. Amongst sodium-phosphate cotransporters, the
subtype NaPi-IIa/b can translocate three Na+ at once while NaPi-IIc only transports two
Na+ despite binding three Na+ [25]. The possibility of Na+-binding site(s) in pfMATE , an
H+-coupled MATE transporter from Pyrococcus furiosus, has been speculated [26], but no
experimental evidence exists.
1.4 Functionally diverse yet structurally similar MATE trans-
porters
The work presented in this thesis investigates members of the secondary-active MATE
transporters. Hence the rest of this chapter explores MATE transporters in detail. The
structural aspect, ion-coupling mechanisms, and modes of ion binding are discussed further.
MATE transporters share 40% similar residues and hence have a similar architecture. MATE
transporters are divided into two classes: the Na+-coupled MATEs and the H+-coupled
MATEs. The first bacterial MATE transporter to be characterized was the Na+-coupled
NorM of Vibrio parahaemolyticus [27]. Subsequently, NorM orthologs from Neisseria
gonorrhoeae [28], and Vibrio cholerae [29] were also characterised. The human genome
harbours H+-coupled MATE transporters that are primarily expressed in the kidney and liver
where they facilitate the final step in the excretion of organic compounds [30] including
compounds of high clinical importance such as metformin, a fist line medication used for
the treatment of type 2 diabetes [31]. Besides affecting drug pharmacokinetics, MATE
transporters are also involved in pathophysiology. For instance, the Escherichia coli MATE
transporter CIbM transports colibactin, a neoplastic genotoxin, and is also involved in the
activation of colibactin [32].
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Fig. 1.3 a, The crystal structure of NorM-VC in the outward-open state (PDB IDs 3MKT and
3MKU). The protein has twelve transmembrane helices which cluster into two distinct lobes.
b, the Rb+-binding site in the C-lobe is composed of amino acid side-chains of differing
chemical natures. Rb+ shown as purple ball.
Owing to their relatively late discovery, less is known about MATE transporters. The
first structural insight into them came when the NorM protein from V. cholerae (NorM-VC)
was crystallised in an outward-open conformation with rubidium ion, and caesium ion,
both of which are more electron-dense analogs of sodium ion [29]. As shown in Fig. 1.3,
the transporter showed a structural organisation different from MFS family proteins; 12
transmembrane helices (TMHs) organise in two distinct bundles (referred to as the N- and
C-lobe) and show a pseudo-two-fold symmetry. The cation-binding cavity is composed of
residues from TMH7, TMH8, and TMH10–TMH12.
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Fig. 1.4 A two-state transport model proposed to explain the drug/cation antiport in NorM-
VC. Na+ shown as red-crossed circle, with the drug shown as pink molecule. a, binding of
sodium to NorM-VC in the outward-open state causes the switch to the inward-open state as
shown in b, the sodium is released as the drug binding takes place. c, the transporter switches
back to the outward-open state and the drug is relased.
Based on the crystal structural, a simple two-state transport model was proposed in which
the cation binds to the outward-open state (Figure 1.4a), which leads to switching to the
inward-open state. The cation is released, followed by the binding of a drug molecule (Figure
1.4b). This, in turn, leads to return to outward-open state (Figure 1.4c). Drug release resets
the transporter for another cycle. The existence of an inward-open conformation, which
brings the residues located near the extracellular termini of the helices closer together, has
been experimentally demonstrated [33] and could corroborate a two-state model for MATE
transporters. However, the existence of relatively short-lived intermediate states can not be
excluded.
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This minimal model suffers from a few drawbacks. For a monovalent cationic drug,
this model should lead to an electroneutral transport reaction. But it has been shown that
NorM-VC can transport ethidium in a ∆ψ-dependent manner [34]. Furthermore, this model
does not allocate any role to the residue D36 (Figure 1.5), which is ubiquitously conserved
in the NorM family of transporters and is likely to have a role in transport. However, in the
crystal structure, D36 is located distal to the metal ion biding site and perhaps that is why no
functional relevance was allocated to it in this transport model.
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Fig. 1.5 Multiple sequence alignment of different NorM proteins. With the exception of
NorM-PS, all NorM proteins shown here have been reported to couple to Na+. Identities are
indicated in red boxes, conserved residues shown in red and the rest shown in black. The
thick black arrows show the conserved carboxylates. the alignment was performed with
ClustalW and the figure was generated with ESPript 3.0.
1.4 Functionally diverse yet structurally similar MATE transporters 11
Crystal structures for six different MATE transporters have been published to date :
NorM-VC [29], NorM-NG [35], pfMATE [36], DinF-BH [37], CIbM [32] and eukaryotic
AtDTX14 [38] . With the exception of DinF, which was crystallised in an occluded state, all
MATE transporters have been crystallised only in outward-open states. This leaves a big gap
in the current knowledge on the role of the inward-open conformation and any other possible
intermediate states.
1.4.1 Drug-cation antiport and Na+ binding in NorM proteins
H+- and Na+ binding in NorM-VC
A paradigm shift in MATE transport biology was brought about when NorM-VC was shown
to be coupled to H+ and Na+ simultaneously [34]. NorM-VC showed improved ethidium
transport in the presence of sodium and proton motive forces (termed ∆pNa and ∆p hereafter)
and the contributions from ∆pNa and ∆p were found to be additive. Ethidium transport by
NorM-VC was found to be dependent on ∆ψ . Since ethidium bears a single positive charge
over a large range of pH values, the dependence on ∆ψ suggests transport of two cations in
exchange for one ethidium molecule.
The D36-region was suspected to be involved in Na+-binding as the N174A mutation
(located in close proximity to D36) leads to a 1200-fold drop in the apparent affinity for
Na+ [34]. A 5-fold decrease in apparent affinity for Na+ was observed for the F288A
mutation (located in the vicinity of E255 and D371), indicating Na+ binding to this location
as suggested by the crystal structure. Furthermore, D371 was shown to be involved in proton
binding in biochemical studies [34]. In molecular simulation studies, the protonation of
D371 was shown to be an important step for the binding of Na+ to NorM-VC [39]. Although
mutations at D371 were shown to cause loss of Cs+-binding in NorM-VC crystals [29], the
D371N mutant still exhibited Na+-dependent ethidium transport with unaltered apparent
affinity for Na+and ethidium in this reaction. Therefore, D371 appears to directly interact
with H+ but not with Na+ in biochemical experiments. Or, it could be possible that in order to
bind Na+, only one carbonyl oxygen is required which is still available in the D371N mutant.
Unlike H+-binding to acidic residues, which is a simpler chemical event, Na+-binding
to protein requires coordination by several side chains or main chain atoms. For example,
in the crystal structure of NorM-VC, the binding of Rb+ or Cs+ appears to be stabilised by
ionic interactions provided by E255 and D371, and also by polar and pi-cationic interactions
provided by Y367 and Y398. The residues D36, in the N-lobe, and E255 and D371, in the
C-lobe, have been shown to be important for the transport reaction as mutating these leads to
either partial or complete loss of transport activity [34]. Substitution of the D371 side chain
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by alanine or asparagine disrupts metal ion binding [29], highlighting the importance of an
ionisable carboxylate group at this position. However, in the crystal structures, no Na+ was
bound near D36.
In molecular simulation studies, protonation of D371NorM-VC was found to lead to binding
of Na+ [39]. Another study found that the V-shaped outward-facing conformation of NorM-
VC (as seen in the crystal structure) is unstable under physiological conditions [40]. Instead,
the protein assumes a conformation with semi-parallel lobes that form an internal cavity
open to the external medium via D36. In this conformation, Na+ interacts with D36 in
the N-lobe first, before finally arriving at the E255/D373 dyad in the C-lobe. Na+ could
bind at the E255/D373 dyad in two distinct ways – either by interacting with both residues
simultaneously or with one of the two carboxylates. This study corroborated the existence of
a conformation different from the outward facing V-shaped state [41] and also confirmed the
biochemical data pointing to importance of D36-region in Na+-binding.
Despite all of the above-mentioned studies, it remains unclear how NorM-VC utilises
Na+ in the transport reaction and what stoichiometry is followed. Also, it remains yet to be
investigated how H+ fits in this reaction. To complicate the situation further, NorM from
Pseudomonas stutzeri (NorM-PS) has been shown to be exclusively H+-coupled [42]. Despite
having 42% identical residues with additional 24% semi-conserved residues, NorM-VC and
NorM-PS appear to have different ion binding preferences. This is surprising given that
the three residues predicted to play key roles in ion-coupling in NorM-VC, namely D36,
E255 and D371, are conserved in NorM-PS (Figure 1.5). These differences in function raise
interesting questions about the cation-binding behaviour in MATE transporters.
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Distinct modes of Na+-binding in different MATE transporters
Similar to observations for NorM-VC, the Cs+ in NorM-NG (PDB ID 4HUL) makes direct
contact with E261 (symmetrical bidentate hence coordination number=2) and Y294 (Pi-
cation interactions). Although D377 is too distant (>7 Å) to interact, a potential donor group
might be S290 that is 5 Å away.
In contrast to NorM-NG, the Rb+ in the ClbM crystal structure makes no close contact
with any of the nearby amino acid side-chains. Whilst the aromatic ring of Y277 is a potential
candidate for pi-cation interactions, the orientation of the F292 ring is unfavourable for the
interaction with the bound Rb+. Overall, the number of interactions evident in NorM-NG
and ClbM structure is less than the usually required coordination number of 5-6 for Na+. It
is possible that a structural water molecule mediates interaction between the metal cations
and amino acid side chains in these transporters. Another possibility is that the substrate
also provides a coordinating group for sodium-binding. Such a case is discussed in the next
section.
1.4.2 Substrate binding and its correlation with metal-ion binding in
MATE transporters
According to the antiport model suggested for NorM-VC [29], drug binding occurs after the
metal cation has been released. This suggests that the binding of Na+ and the substrate would
be mutually exclusive in a biochemical ping-pong mechanism. For NorM-VC, this model
is discordant with the observation that the binding of ethidium monoazide, a fluorescent
analogue of ethidium that binds covalently, was shown to be enhanced in the presence of
Na+ [34]. Similarly, another study showed that other substrates, but not Na+, compete with
Ruboxyl binding to purified NorM-VC [43].
The existence of a state where Na+ and the substrate could bind simultaneously is also
suggested for NorM-NG [35] where the Cs+-binding cavity is distal to the tetraphenylphos-
phonium (TPP) binding site. The drug-bound conformation is not very different from the
Cs+-bound conformation and upon superimposing the two conformations, the Cs+ ion and
TPP do not sterically hinder; instead, under physiological conditions they can be at an optimal
distance to interact with each other. Alternatively, they could interact with each other via
a water molecular. It is reasonable to suspect that the aromatic phenyl rings of TPP might
be one of the coordinating partners. The possibility of direct interactions between the drug
(ethidium) molecule and Na+ in NorM-VC transport cycle cannot be ruled out, either.
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Fig. 1.6 a, The substrate and Cs+ occupy two distant sites in NorM-NG. TPP+ (shown in
red) -bound conformation shown as purple ribbons, Cs+ (shown in blue)-bound conformation
shown as green ribbons. b,The distances between the approaching rings of TPP and Cs+ are
shown. The two structures (PDB ID: 4HUL and 4HUK) were superimposed using UCSF
Chimera.
In summary, despite having conserved carboxylates, bacterial MATEs probably coordi-
nate metal-ions by different mechanisms. It is also noteworthy that crystal structures are
generated under non-native conditions where crystal contacts might influence the protein
conformation and subsequently the intra-molecular interactions in the protein.
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1.5 H+-coupled MATE transporters
H+-coupled MATE transporters pfMATE and DinF-BH provide a useful contrast to Na+-
coupled MATE transporters - both in terms of primary structure and proposed mechanisms
of ion-coupling. These proteins do not contain equivalent carboxylates of E255NorM-VC and
D371NorM-VC in the C-lobe. Instead, in pfMATE, D41 (the counterpart of D36NorM-VC) is
complemented by another carboxylate, D184, situated in the N-lobe. The same is true for
DinF-BH which contains D40 and D184 in the N-lobe.
Fig. 1.7 A cartoon representation of NorM-VC (a and b) and pfMATE (c and d) crystal
structures depicting the positioning of the catalytic carboxylates. H+-coupled pfMATE has
two spatially-adjacent carboxylates in the N-lobe that take part in H+-binding, whereas
NorM-VC has only one carboxylate in this position but has two vicinal carboxylates in the
C-lobe. PDB IDs: 3MKU (NorM-VC) and 3VVN (pfMATE).
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In the crystal structure, pfMATE, like most other MATE transporters, is seen in an
outward-open conformation but the pH-dependent conformational changes in TMH1 are
strikingly different from those seen for any of the previously reported MATE structures [36].
At neutral pH, TMH1 has a straight conformation in which either D41pfMATE or D184pfMATE
is protonated. But at pH 6.0, the rearrangement of the H-bond network causes TMH1 to
assume a bent conformation in which both D41pfMATE and D184pfMATE are occluded in a
water-inaccessible cavity and may both be protonated via sharing the same proton. The TMH1
seems to bend at P26 and G30 (significant torsional changes take place at G30). Following
these findings in pfMATE, similar observations were made in eukaryotic H+-coupled MATE
transporters as discussed in the next section.
1.6 MATE transporters in eukaryotes
The crystal structure of a eukaryotic MATE transporter from Arabidopsis thaliana (AtDTX14)
provided new insights into the mechanism of eukaryotic MATE transporters [38]. With 32%
sequence identity with the human MATE transporter hMATE1, the mechanism is quite
relevant and can be extrapolated to explore hMATE1.
1.6.1 Common structural elements in bacterial and eukaryotic MATE
transporters
An interesting pattern emerges upon comparing the positioning of catalytic carboxylates
in bacterial and eukaryotic MATE transporters. AtDTX14 does not have an equivalent
carboxylate in the N-lobe of NorM proteins. Instead it has E273hMATE1 and E389hMATE1in
the C-lobe. The positioning of carboxylates here is opposite to pfMATE and DinF-BH which
lack active site carboxylates in the C-lobe but have two vicinal carboxylates in the N-lobe.
The C-lobe carboxylates in AtDTX14 are very close to each other, forming a H-bond, brought
about by the low pH of the crystallisation medium. Furthermore, the structural changes in
the TMH7 are brought about by a kink introduced at P257 which is part of a GXP motif.
This GXP motif is conserved in NorM and DinF family proteins and is replaced by AXP in
hMATE1 and hMATE2.
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Fig. 1.8 a, Multiple sequence alignment of MATE family members showing the conserved
GXP motif in the TMH7 that connects N-lobe with the C-lobe. Identities shown in red
boxes, semi conserved resideus shown in red, and the rest shown in black. b, The TMH7 in
eukaryotic MATE AtDTX14 (PDB ID: 5Y5O) bends at G255 (part of the GXP motif). This
bending is brought about by protonation of E265/D383 dyad. c, The bending of TMH7 in
NorM-VC (PDB ID: 3MKU) brings E255 and D371 closer and orients E255 to face D371.
However, the indispensability of these two amino acids in the GXP motif is debatable.
In this regard, the observations made for pfMATE are interesting. pfMATE uses a PXXXG
motif to induce the kink in TMH1. Upon comparing the straight and bent conformations of
pfMATE, the kink is seen at the residues succeeding G30, and the conformation around P26
remains the same. Yet, mutating the P26 (and not G30) causes disruption of drug/H+ antiport
[36]. Perhaps in the absence of a ‘flexible’ residue, the torsion transmits over a larger distance
along the helix which still allows the transport related dynamics to take place. Anyhow, the
possibility that these bi-symmetrical transporters probably resulted via a gene duplication
event cannot escape one’s notice. The mirroring of TMH1pfMATE by TMH7AtDTx14 further
supports this hypothesis.
This thesis is presented in 7 chapters. A brief description of the contents of these chapters
follows here.
Chapter 1 introduces MATE transporters and provides a summary of the current views
on their mechanisms of transport. The chapter also summarizes the structural information
available for MATE transport proteins.
Chapter 2 provides an overview of the methods and materials used to conduct this
research. Relevant molecular biology and biochemical techniques are described in detail.
Chapter 3, the first of four results chapters, details fundamental differences between the
ion requirements of NorM-VC and NorM-PS. The chapter gives an account of the properties
of chimeric proteins that I prepared using NorM-VC and NorM-PS. It also provides evidence
for cooperativity between the two transmembrane helical bundles (lobes), which allows Na+
transport by NorM-VC.
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Chapter 4 demonstrates a relationship between proton and sodium ion availability, and
the observed ion-dependence of NorM-VC. Evidence for a correlation between pH and Na+
coupling, and correlation between pH and substrate binding is also provided.
Chapter 5 describes the rational design of NorM-PS and NorM-VC mutants with the
objective of achieving altered ion specificity in the drug transport process. The structure-
function relationships of the two transporters are discussed.
Chapter 6 describes a novel pathway for Na+ movement through NorM-VC. Biochemical
experimental evidence is presented which confirm the pathway. The prediction of this
pathway explains the observations made in chapter 3.
In the final Chapter 7, a transport model is proposed to explain my observations and
those in published studies. The model is discussed with respect to the findings presented by
other studies. The thesis finishes with a discussion of further lines of research.
1.7 Scope of this thesis
The work presented here focuses on the ion-coupled drug transport by NorM-VC and NorM-
PS. The basic premise of the study is the difference in the ion-coupling in transport reactions
by otherwise highly homologous proteins. A bioenergetics aspect, supplemented with struc-
tural relevance, is provided. The work begins by laying down some fundamental differences
in the energetics of the two transporters and concludes with an experimentally confirmed
novel transport mechanism for NorM-VC. The work here deals with some fundamental
questions relating to transport across energy-conserving membranes and, at the same time,
bears high clinical significance. Such knowledge will add to the current understanding of
transport biology and has the potential to help address the issue of drug resistance.
Chapter 2
Methods and Materials
2.1 Risk assessment and safety procedures
The laboratory protocols were risk assessed as per Department of Pharmacology safety
guidelines and local rules. A chemical safety course was taken prior to the lab work. Non-
virulent E. coli strain DH5α was used for molecular biology purposes. For expression of
proteins, L. lactis (subsp. cremoris) was used. L. Lactis is a food grade bacterium and is safe
to use at the lowest biosafety class 1 containment level. Ethidium bromide was used with
caution while avoiding contact with body parts. Ethidium bromide containing waste was
decanted into a container with charcoal bags, which were disposed of by incineration. 2-4,
dinitrophenol (DNP) was weighed wearing personal protection equipment, and waste was
collected for disposal by the Safety Office, University of Cambridge. Protocols involving use
of high-speed centrifuges, UV-based gel visualisation units and liquid nitrogen tanks were
carried out after risk assessment and safety inductions.
2.2 Bacterial strains, media and growth conditions
The drug-hypersensitive L. lactis ∆lmrA ∆lmrCD [44], [45] was used as the host for protein
expression and transport studies. It contains expression vector pNZ8048 derived plasmids
[45] with a chloramphenicol resistance marker gene, nisin A-inducible Pnis promoter and
N-terminally 6× His-tagged proteins of interest. The same strain with empty control vector
(pNZ8048) was used as a negative control. The cells were grown in M17 broth supplemented
with 25 mM glucose containing 5 µg/mL chloramphenicol at 30°C in all experiments unless
stated otherwise. Glycerol stocks were streaked on M17-agar plates supplemented with 25
mM glucose containing 5 µg/mL chloramphenicol, and incubated for 24-36 hours at 30°C.
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Single colonies were grown overnight and stored in 25% glycerol at -80°C. For molecular
biology purposes, E. coli DH5α cells were used. The cells were grown in LB medium
supplemented with 100 µg/ml carbenicillin when required.
For preparing competent E. coli cells, cells were grown to an O.D.600nm (optical density
at 600 nm) of 0.35-0.4 and washed twice with chilled 100 mM CaCl2. The cells were kept on
ice prior to use. The plasmid DNA (2-5 µL of ligation product containing 5 ng total DNA)
was added to 50 µL aliquots of competent cells and the cells were further kept on ice for 30
minutes. The cells were heat shocked by incubating cells at 42°C for 45 seconds. The cells
were incubated on ice for 2-5 minutes and 1 mL of LB media was given to induce recovery.
The cells were then incubated at 37°C with constant shaking at 200 rpm for an hour after
which the cells were collected by centrifugation. Finally, the pellet was resuspended in LB
medium and plated on carbenicillin containing LB-agar. The plates were incubated at 37°C
overnight.
Electrocompetent L. lactis cells were prepared as described previously [46]. The cells
were grown in an osmotically-stabilised M17 medium containing 0.5 M sucrose, 1% glycine
and 25 mM glucose. The presence of glycine ensures growth of single-celled L. lactis
population. An overgrown culture was diluted 100-fold in fresh medium and incubated
at 30°C to an O.D.660nm of 0.4. The cells were then washed twice using wash solution
containing 0.5 M sucrose and 10% glycerol. The cells were snap-frozen and stored at -80°C.
2.3 Cloning, subcloning and mutagenesis
2.3.1 Cloning the norM-PS gene into pET19b vector
All the molecular biology experiments were performed on E. coli vector pET19b prior to
subcloning into L. lactis pNZ vector. The reason behind not using pNZ vectors directly was
that in the experiments, parental pNZ vectors did not get digested by DpNI. DpNI digestion
is a critical step for separating parental plasmid DNA from mutated plasmid DNA after PCR
reaction.
The molecular biology enzymes used, were ordered from ThermoScientific (unless stated
otherwise) and the reactions were carried out as per the product manual. All restriction
enzymes were of the FastDigest category and required the same universal buffer. The DNA
was eluted in nuclease-free water and stored at -20°C until use.
The norM-PS sequence (GenBank ID EHY79494.1) was codon-optimised for L. lactis
subspecies cremoris using the online codon optimisation tool from Integrated DNA Tech-
nology (IDT). The NdeI and XhoI restriction sites were added on the ends and the resulting
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sequence was synthesised by IDT. 250 ng of the synthesised gene was digested using NdeI
and XhoI restriction enzymes, and spin column purified using the Thermo Scientific GeneJET
Gel Extraction Kit. The DNA concentration was determined using UV absorbance at 260
nm.
The pET19b vector harbouring the norM-VC gene [29] was digested with NdeI and XhoI
restriction enzymes and was agarose-gel purified. The norM-PS gene insert was ligated
as an NdeI and XhoI fragment into the digested vector. The ligated vector was used to
transform chemically competent E. coli DH5α cells and transformed cells were selected by
growing overnight on 100 µg/ml carbenicillin containing LB-agar plates at 37°C. Single
colonies were picked, grown overnight in LB medium supplemented with carbenicillin and
subsequently the plasmid DNA was purified. Prior to subcloning into pNZ vector, all genes
were sequenced by using the tube sequencing service provided by Eurofins Genomics.
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Fig. 2.1 The molecular biology workflow for cloning the synthetic norM-PS gene into
pET19b vector.
2.3.2 Subcloning the norM-PS gene into pNZ vector
The pET19b-norMPS vector was digested with NcoI and BamHI and the released insert was
agarose gel purified. The insert was ligated into pNZ-NorM-VC which had been digested
with the same enzymes.
The ligation product was used to transform electrocompetent L. lactis cells. The electro-
competent cells were mixed with plasmid DNA and electroporated using a MicroPulser™
electroporater from BioRad. The pulse was given using the preset conditions EC3 3.00 kV,
single pulse, 0.2 cm cuvette. After the pulse, an ms value of 5.4-6.0 was achieved. The
cells were quickly mixed with recovery buffer (M17 supplemented with 0.5 M sucrose, 25
mM glucose, 20 mM MgCl2 and 2 mM CaCl2) and kept on ice for 10 minutes followed
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Fig. 2.2 The molecular biology workflow for cloning the synthetic norM-PS gene into
pET19b vector and the subcloning into pNZ vector.
by incubation at 30°C for 2 hours. The cells were centrifuged and the resulting pellet was
resuspended in 100 µL of recovery buffer and plated on M17-agar plates containing 0.5 M
sucrose, 25 mM glucose and 5 µg/ml chloramphenicol. After incubation at 30°C for 36-48
hours, single colonies were picked and grown overnight for plasmid isolation.
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2.4 Site directed mutagenesis
For the introduction of point mutations in norM genes, the QuikChange site-directed mu-
tagenesis method was used as per manufacturer’s instructions. Alternatively, the method
described here [47] was also used in cases where the QuikChange method was not efficient
due to primer-dimer formation. This method, colloquially referred to as the Round-the-Horn
method, utilises two non-overlapping primers, one of which contains the desired mutation at
the 5’ end (Figure 2.3).
Fig. 2.3 The Round-the-horn (RTH) method of site-directed mutagenesis. In contrast to the
QuikChange method, this method requires phosphorylation of the primers and an additional
ligation step but due to short length (∼20 bases) of primers, the annealing temperature of the
primers can be regulated more easily. Also, as the mutagentic primers contain the mutations
at the 5’ end, the annealing is better controlled. RTH also allows introduction of multiple
subsequent mutations in one PCR reaction.
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The primers were designed to have a melting temperature of 60°C and were phosphory-
lated using polynucleotide kinase (PNK) as per product manual. The phosphorylated primers
were directly used in the mutagenic PCR reactions. A typical 50 µl PCR reaction consisted
of 1X HF buffer (provided with the DNA polymerase kit), 0.2 mM dNTPs, 10 µM forward
and reverse primer, 10 ng plasmid DNA template and 1 unit of Phusion DNA polymerase.
The PCR cycling parameters were 98°C for 1 min, (98°C for 15 sec, 55°C for 30 sec, 72°C
for 30 sec/kb) × 20-25 cycles, 72°C for 5 minutes. The amplified product was detected using
agarose gel electrophoresis. After PCR amplification, parental DNA was digested by adding
1 µL of FastDigest DpnI to 20 µL of DNA mixture containing 1x FastDigest buffer and
the reaction mixture was incubated at 37°C for 30-60 minutes (1 µL of FastDigest enzyme
cleaves 1 µg of substrate DNA in 5 to 15 minutes in 20 µL of FastDigest buffer). Undigested
DNA was gel purified and ligated (optional in case of QuikChange). The DNA was finally
used to transform chemically (CaCl2) competent E. coli (DH5α) cells.
Table 2.1 Primers used for site-directed mutagenesis
Mutation Method Primer sequence
NorM-VC F429L Round the horn
ttaatcatcggactctcggcgg
tccgagccagaaacctttggc
NorM-VC L430F Round the horn
tttatcgcgggtttaagttgtgc
cccttgccataacccagatgg
NorM-VC L426F Round the horn
ttttggcaagggttaatcgcggg
cccagatggaccgctagctg
NorM-PS F369Y Round the horn
taccagttcagcgatgtagtacagg
aagagcggcgtaaaaaaaaagccc
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2.5 Chimeric genes generation
The first chimera is named NorM-VC(NL)NorM-PS(CL) referring to the protein consisting
of N-lobe (NL) of NorM-VC (amino acid residues 1-225) and C-lobe (CL) of NorM-PS
(amino acids residues 227-464). Similarly, the second chimera is named NorM-PS(NL)NorM-
VC(CL) referring to the protein consisting of N-lobe of NorM-PS (amino acids 1-227) and
C-lobe of NorM-VC (amino acid residues 226-461). The NorM-VC and NorM-PS chimeras
were generated using FastCloning method as described previously [48]. The flow chart below
summarises the overall procedure and primer design.
Fig. 2.4 The FastCloning method workflow for chimera generation. This method is digestion
and ligation free and allows quick generation of chimeras is a three-step (PCR, DpnI digestion
and transformation) protocol.
A 50 µl PCR reaction mixture consisted of 1X HF buffer (provided with polymerase kit),
0.2 mM dNTPs, 5 picomoles of each primer, 10 ng plasmid DNA template and 0.5 µl of
Phusion DNA polymerase. The PCR cycling parameters were 98°C for 1 min, (98°C for 15
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sec, 55°C for 30 sec, 72°C for 30 sec/kb) × 18 cycles, 72°C for 5 minutes. The product was
confirmed using agarose gel electrophoresis.










The primer pair NorM_VC_A_fw and NorM_VC_A_rev were used to amplify the
first half of NorM-VC (residues 1-225) along with the pET19b vector. The primer pair
NorM_PS_B_fw and NorM_PS_B_rev were used to amplify the second half of NorM-PS
(residues 227-464). After PCR amplification, 1 µl of DpnI was added to the PCR products
and, the two reaction mixtures were pooled together in the ratios 1:1, 1:2, 1:4 and incubated
at 37°C for 1 hour to digest the template DNA. 2 µl of the digested product was used to
transform competent E. coli DH5α cells.
2.6 Protein expression, purification, quantitation, and pu-
rity determination
2.6.1 Preparation of inside-out membrane vesicles (ISOVs) from L. lac-
tis cells
For protein expression, M17 growth medium containing 25 mM glucose and 5 µg/ml
chloramphenicol was inoculated with 2.5% overnight culture and grown to an OD600 nm of
0.5-0.6 at 30°C. Protein expression was induced by addition of 0.1% (v/v) of the culture
supernatant of the nisin A-producing strain L. lactis NZ9700 [49], which gives a final
concentration of approximately 10 pg nisinA /ml. Cells were further grown for one hour
and were collected by centrifugation at 7,500 rpm for 12 minutes, at 4°C (Sorvall Evolution
RC, SLC-6000 rotor). The pellet was resuspended in ice-cold 100 mM potassium phosphate
(KPi) buffer (pH 7.0) and centrifuged at 4,400 rpm for 30 minutes at 4°C. The cell pellet
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(collected from 1 L culture) was resuspended in 20 ml KPi (pH 7.0) containing 5 mg/mL
lysozyme (from chicken egg white) and a tablet of Complete-Protease inhibitor cocktail and
incubated for 30 minutes at 30°C. Cell lysis was performed by passing the cell suspension 2-3
times through a Basic Z 0.75 kW Benchtop Cell Disruptor (Constant Systems, Northlands,
UK) at 20 kpsi. The suspension containing lysed cells was supplemented with 10 µg/mL
DNAse and 10 mM MgSO4 and incubated for 30 minutes at 30°C to digest cellular DNA. 15
mM K-EDTA (pH 7.0) was added to prevent the aggregation of the membrane vesicles. In
order to remove cell debris and unbroken cells, centrifugation was carried out at 4°C for 40
minutes at 8000 rpm (Sorvall Evolution RC-6 PLUS, F21S rotor). Supernatant containing
the membrane vesicles was retained and ultra-centrifuged at 37,000 rpm for 50 minutes at
4°C (Beckman Type-50.2-Ti rotor). The pellet was resuspended in 50 mM KPi (pH 7.0)
containing 10% glycerol, and stored in liquid-nitrogen.
2.6.2 Purification of His-tagged proteins
The protein of interest was purified from inside-out membrane vesicles (ISOVs) using metal
ion-affinity chromatography. ISOVs (5 mg membrane protein/ml) were added to 50 mM
KPi (pH 8.0), 10% (v/v) glycerol, 0.1 M KCl and 1% (w/v) n-dodecy-β -D-maltopyranoside
(DDM) for 4 hours with mild shaking at 4°C. Non-solubilized membrane vesicles and
cell debris were removed by centrifuging the mixture at 55,000 rpm , 4°C for 30 minutes
(Beckman Type-70.1-Ti rotor). Nickel-nitrilotriacetic acid resin (Ni-NTA) was equilibrated
by washing thrice with 5 resin volumes of MilliQ water, and twice with 5 resin volumes of
wash buffer A (50 mM KPi (pH 8.0), 0.1 M KCl, 10% (v/v) glycerol, 0.05% (w/v) DDM
and 20 mM imidazole), at a ratio of 10 mg His-tagged protein/mL of resin. The suspension
was left on a rotating wheel for overnight binding at 4°C, after which the unbound proteins
were removed by centrifugation, and the resin was transferred to a 2 mL volume Biospin
disposable chromatography column (Bio-Rad). After subsequent washing with 20 volumes
of wash buffer A and 30 volumes of wash buffer B (50 mM KPi (pH 7.0), 0.1 M KCl, 10%
(v/v) glycerol, 0.05% (w/v) DDM and 20 mM imidazole (pH 8.0). The His-tagged protein
was eluted with 3-4 volumes of elution buffer (50 mM KPi (pH 7.0), 0.1 M KCl, 5% (v/v)
glycerol, 0.05% (w/v) DDM and 150 mM imidazole (pH 8.0). The eluted purified protein
was kept on ice and was immediately used in experiments. The purity of the protein was
checked by on a 10% Sodium dodecyl sulphate-poly acrylamide gel (SDS-PAGE) stained
with Coomassie Brilliant Blue.
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2.6.3 Protein concentration determination
Protein concentration in the membrane vesicles was determined by Bio-Rad DC protein
assay kit. A standard curve was prepared by plotting the absorbance at 750 nm versus
varying concentrations of bovine serum albumin (BSA). 20 µl of samples containing 0,
0.25, 0.5, 0.75, 1, 1.25, 1.5 mg/ml BSA was mixed with 100 µl of Solution A and 800 µl
of Solution B. After 15 minutes of incubation, absorbance at 562 nm was measured. 10,
20, and 50-fold dilutions of the ISOVs were prepared and the absorbance at 750 nm was
used to determine the protein concentration by using the standard curve equation. Purified
protein was quantified by Micro BCA (ThermoScientific) protein assay kit (catalog number
23235) which is more sensitive and does not cross-react with detergents. A standard curve
was prepared by plotting the absorbance versus varying concentrations of bovine serum
albumin (BSA). Samples containing 0, 0.5, 1, 2, 5, 10, 15, 20 µg/ml BSA was mixed with
equal volume of colouring solution (25 parts solution MA + 24 parts Solution MB + 1 part
solution MC). After 15 minutes of incubation, absorbance was measured and the protein
concentration was determined by using the standard curve equation.
2.6.4 Protein detection and purity determination
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was used to
detect the proteins in ISOVs and in purified samples. ISOV samples containing equal
amounts of total protein were denatured in SDS sample-loading dye (6X sample buffer:
10% SDS, 30% glycerol, 1.2% bromophenol blue, 62.5 mM Tris-HCl (pH 6.8), 0.715 mM
βC-mercapto-ethanol, 6 mM EDTA free-acid , 50 mM dithiotriol) and were separated on
10% resolving/separating gel (pH 8.8) and 5% stacking gel (pH 6.8). A pre-stained protein
marker (6µL) was also loaded to estimate protein size by comparing the migration of standard
proteins in the marker. The gel was run in 1x tris-glycine running buffer (25mM Tris-base,
250 mM glycine, 0.1 % SDS, pH 8.3) at 80 volts until the dye front reached the resolving
gel and then at 100 volts until the dye front ran over. Separated proteins were visualized by
staining the gel with Coomassie blue (0.1 % Coomassie Brilliant Blue (w/v), 45 % methanol,
45 % distilled water, 10 % glacial acetic acid). The gel was destained using the destaining
solution (45% methanol, 45% distilled water, 10% glacial acetic acid) overnight and finally
washed with MilliQ water for visualising the bands.
For western blotting, proteins separated on SDS-PAGE gels were electro-blotted onto
PVDF membrane (0.45µm ImmobilonTM Transfer membranes) in cold transfer buffer (12.5
mM Tris-base, 100 mM glycine and 20% methanol) at 100 volts, 4°C for an hour. To avoid
non-specific binding, the membrane was blocked using TBST (Tris-buffered saline, 0.1%
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Tween-20) containing 5% (w/v) skimmed milk powder for 30 minutes at room temperature
with mild shaking. The membrane was washed with TBST three times and a 1:1000 to 1:3000
dilution of anti-His primary antibody (Sigma Aldrich, catalog number SAB1305538) was
added and the membrane was incubated for 1 hour at room temperature. The blot was washed
thrice with TBST and incubated with 1:5000 dilution of secondary antibody (horseradish
peroxidase HRP-conjugated anti-mouse IgG from Sigma Aldrich, catalog number A9917)
for 1 hour at RT. The membrane was again washed thrice with TBST. The membrane was
incubated with the Enhanced Chemiluminescence system (ECL) solution for 5 minutes.
Finally, the signals were detected by exposing the membrane to X-ray film for varying
durations or using Biospectrum Imaging System.
2.7 Measurements in whole cells
2.7.1 Ethidium efflux assay
MATE protein expressing cells were harvested by centrifugation and washed with ice-cold
50 mM KPi (pH 7.0) supplemented with 5 mM MgSO4 by centrifugation at 3000g for 8 -10
minutes. Cell pellet was re-suspended in 0.6 mM 2,4-dinitrophenol (DNP) containing wash
buffer at 30°C for 40 minutes. DNP shuttles protons into the cytosol and in order to maintain
the pH gradient, cells pump out protons by hydrolysing ATP until the intracellular ATP levels
drop to micromolar levels. The deenergised cells were then washed thrice with ice-cold buffer
by centrifugation at 3000 g for 8 -10 minutes. the cells were re-suspended in the same buffer
to attain a cell density corresponding to OD660 nm 5.0. The cells were diluted 10 times in 2 ml
of the same buffer in a 3 ml cuvette at 30°C. After 30 seconds, 2 µM ethidium bromide was
added and fluorescence was monitored (excitation wavelength=500nm, slit width=5 nm and
emission wavelength=580 nm, slit width=10 nm) using LS-55B Luminescence spectrometer
(Perkin Elmer, Norwalk, CT). After reaching a saturation in fluorescence, 25 mM glucose
was added to energise cells and to trigger efflux. The ethidium fluorescence was monitored
for 10-15 minutes.
2.7.2 Membrane potential measurement in L. lactis cells
The cells expressing NorM-VC or control cells (empty vector pNZ8048) were de-energised
by DNP treatment as described in ethidium efflux assay method. The cells were diluted 10
times in 50 mM KPi (supplemented with 5 mM MgSO4) buffers with different pH values
(6, 7, and 8) to attain a cell density corresponding to OD660 nm 0.5 in a glass cuvette. The
cells were re-energised by addition of 12.5 mM glucose and incubation at 25°C for 3
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min. A membrane potential-sensitive fluorescent probe, 3,3’-Diethyloxacarbocyanine Iodide
(DiOC2(3)) (Thermo Scientific, catalog number D14730) was employed to monitor the
transmembrane potential in L. lactis using a LS-55B luminescence spectrometer (Perkin
Elmer). The parameters were set as follows: (excitation wavelength = 488 nm, slit width=5
nm; emission wavelength= 620 nm, slit width=10 nm). 10 µM DiOC2(3) was added and
when a steady-state level of fluorescence was reached, 0.5 µM nigericin was added to
interconvert ∆pH into ∆ψ . After saturation, 0.5 µM valinomycin was added to completely
abolish ∆p.
Fig. 2.5 A typical DiOC2(3) fluorescence trace indicating different components of cellular
proton motive force. The probe DiOC2(3) accumulates in negative cellular compartments
and hence indicates the ∆ψ . Upon addition of nigericin, the ∆pH is interconverted into ∆ψ
and a rise in fluorescence is seen with the top value being indicative of the total ∆p. Further
addition of valinomycin completely abolishes the ∆p and the fluorescence drops to the basal
level (the value used for baseline correction). The difference between ∆p and ∆psi gives
∆pH.
The fluorescence levels corresponding to cells with no ∆p were taken as the baseline
fluorescence due to DiOC2(3) binding to cells and was subtracted from the original fluores-
cence traces. After baseline correction, the fluorescence after DiOC2(3) addition was taken
as ∆ψ , the fluorescence after nigericin addition was taken as ∆p. The ∆pH was deduced by
subtracting ∆ψ from ∆p. The picture below shows how the various phases of the traces were
interpreted and analysed.
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2.8 Ethidium binding assays using fluorescence anisotropy
The anisotropy measurements shown in figures 3.7, 3.13, 5.7, 6.2 and 4.5 were made using
a Perkin Elmer LS55 spectrophotometer. The instrument uses the following formula to
calculate anisotropy:
Anisotropy = (Ivv-(GF×Ivh))/(Ivv+(2×GF×Ivh)
Where Ivv is the intensity with both polarisers (excitation and emission) vertical, Ivh is the
intensity with polarisers vertical and horizontal (excitation and emission). The GF (grating
factor) is instrumental polarisation correction factor and was calculated using the software.
The anisotropy measurements shown in Figure 6.7 here , were made using CLARIOstar
microplate reader from BMG LABTECH. The samples were read in a 96-well plate with
black bottom. The focus adjustment was done at a well with least amount of protein. The
gain was maintained at 10%. Other parameters were kept the same as for the readings with
Perkin Elmer LS-55 spectrophotometer.
For measuring the anisotropy, a protein solution at a concentration of 0.4 mg/ml was
used. Increasing amounts of the proteins were added to 2 ml of assay buffer containing 50
mM KPi (pH7.0), 0.2 M KCl, 0.05% DDM and 2 µM EtBr. The excitation and emission
wavelengths were the same those in the ethidium efflux assay. The protein concentration
ranged from 0.036 µM to 1 µM. 0.5 mM of Na2SO4 was added to the buffer to test the effect
of Na+ on ethidium binding to the proteins. To test the effect of protons on ethidium binding,
the pH of the buffer was varied from 6 to 9 in 0.2 steps by addition of either HCl or KOH.
The protein elution buffer was used as a negative control to generate the base line.
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2.9 Computational studies and data processing
2.9.1 The pKa estimations of the ionisable groups in the target proteins
The pKa calculations were done using the online tool H++. The submitted files were either
the original PDB files (without the metal-ion) or homology models based on the crystal
structures. The parameters were kept to their default values.
2.9.2 Homology modelling
The MurJ based homology model of NorM-VC was made by using SWISS-MODEL. The
"User Template" option was selected to provide NorM-VC sequence (PDB IS: 3MKU) and
MurJ structure (PDB ID: 5T77).
2.9.3 Data analysis and plotting
The data were analysed and plotted using GraphPad Prism 6.0 packages.
All molecular visualisation images were generated using UCSF chimera. A list of online
resources and URLs has been provided in Appendix A.
2.9.4 Statistical analyses
All measurements were done in independent triplicate studies unless indicated otherwise.
Two-way ANOVA (multiple comparisons) test provided with GraphPad Prism 6.0 was
employed to test for statical significance between pairs of data sets. A description of the
symbols used to indicate statistical significance in this thesis is given below.
Table 2.3 P-Value symbols
Symbol P-Value
ns P > 0.05
* P ≤ 0.05
** P ≤ 0.01
*** P ≤ 0.001
**** P ≤ 0.0001

Chapter 3
Different ion-coupling requirements of
NorM-VC and NorM-PS
Transporters in the MATE family were originally thought to be either Na+- or H+-coupled.
For example, the NorM subfamily is thought to be solely dependent on Na+ cycling whereas
the DinF family is dependent on H+ cycling. However, the transport assays with NorM-
VC in cells and proteoliposomes [34] indicated that NorM-VC couples to H+ and Na+
simultaneously. In contrast, NorM-PS was reported to be exclusively H+-coupled [42]. In
this Chapter, I examined these claims by testing the ion coupling and overall energetics of
NorM-VC and NorM-PS proteins under identical experimental conditions.
3.1 Cloning of the norM-PS gene
The NorM-PS gene was custom synthesised and cloned between the Nde1 and Xho1 sites
of the pET19b vector. The product was used to transform E. coli DH5α cells. Single
transformant colonies were picked and grown overnight to isolate the plasmid DNA. The
purified plasmid DNA was double digested and run on a 1% agarose gel to visualise the
inserted NorM-PS gene. The insert was verified by DNA sequencing and the translated
polypeptide chain had 100% identity with the original sequence (GenBankTM EHY79494.1).
The NorM-PS gene was isolated from pET19b-NorM-PS by digesting with NcoI and
BamHI. The digested fragment was then ligated into digested pNZ8048 vector (derived from
pNZ-NorM-VC construct). The subcloned gene was sequenced and had 100% amino acid
identity with the original sequence.
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Fig. 3.1 The vector pET19b-NorM-PS was digested with NdeI and XhoI and run on an
agarose gel to confirm the presence of the insert. Besides the double-cut vector, a fragment
consistent with the size of norM-PS gene was seen which was cut out and purified for
subcloning into the pNZ8048 vector.
Fig. 3.2 The vector pNZ-NorM-PS was digested with NcoI and BamHI and run on an agarose
gel to confirm the presence of the insert. Besides a single-cut and a double-cut band, a band
consistent with the size of norM-PS gene was seen.
3.2 NorM-VC and NorM-PS couple differently to ion gra-
dients to export ethidium
Ethidium is a substrate for many multidrug transporters and has been used to assay their
transport activity [50]. It is a lipophilic cationic compound that upon accumulation into
the intracellular compartment, binds to nucleic acids and shows enhanced fluorescence
emission. In preparation for the ethidium export assay, the protein-expressing cells were
first de-energised in presence of dinitrophenol (protonophore), washed with Kpi buffer and
finally resuspended in the same buffer. The cells were then incubated with ethidium and
after the fluorescence eqillibrated, glucose was added to cells, optionally along with different
cation salts. As shown in Fig. 3.3, NorM-VC exported ethidium in the presence of ∆p which
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further improved in the presence of Na+. Whereas NorM-PS also exported ethidium in a ∆p
dependent manner, no stimulation of efflux by Na+ was observed.
Fig. 3.3 a, NorM-VC as well as NorM-PS expressing cells show significant ethidium extrusion
compared to control cells containing empty vector pNZ8048. The addition of 1 mM Na+
caused enhanced extrusion activity for NorM-VC. In contrast, no stimulation was observed
for NorM-PS. Solid and dotted lines refer to the absence and presence of Na+. b, The
bar chart shows mean (±SD) end levels of ethidium fluorescence after extrusion. N=3
(independent studies).
To further test the ion selectivity of NorM-VC and NorM-PS, a transport assay similar
to Figure 3.3 was employed where KPi buffer was replaced by 25 mM Tris buffer (pH 7.0)
supplemented with 5 mM MgSO4. K+ has been shown to be involved in generation of a pH
gradient via an indirect K+/H+ exchange reaction in bacterial cells [51]. Under deenergised
conditions, cells are dependent on extracellular K+ for generating a proton gradient. Under
these conditions, cells loaded with ethidium can be selectively given either K+ (to allow
generation of ∆pH) or Na+ (to generate ∆pNa).
As shown in Fig. 3.4, after loading the cells with ethidium and further energisation with
glucose, neither NorM-VC nor NorM-PS exported ethidium due to the lack of ∆pH in the
absence of K+.
However, upon addition of K2SO4 along with glucose, both NorM-VC and NorM-PS
showed a considerable ethidium export, further corroborating the H+-coupled ethidium
transport by the two. Finally, in presence of glucose and Na2SO2, only NorM-VC exported
ethidium pointing to direct Na+ coupling in NorM-VC (Fig. 3.4b). It could be argued that
upon addition of Na+, ∆pNa is converted into ∆pH in L. lactis cells which, in turn is coupled
to ethidium export but the inability of NorM-PS to export ethidium under these conditions
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(Fig. 3.4a) proves that NorM-VC-mediated efflux is directly coupled to Na+ cycling. These
results indicate that NorM-VC is more versatile in terms of its ion requirements in the antiport
reaction. But how is this versatility achieved?
Fig. 3.4 a, In absence of extracellular K+, the L. lactis cells expressing NorM–PS showed no
ethidium export upon addition of glucose only. However, ethidium export was seen upon
addition of 10 mM K+ (∆p) alongside glucose b, NorM-VC can export ethidium in presence
of 10 mM K+ or 10 mM Na+. The transport was abolished following the addition of nigericin
which dissipates the ∆pH.
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To test whether the pH of the assay buffer has any effects on the ion preference of NorM-
PS, the same assay was performed at acidic and basic pH values. It was hypothesised that
an altered protonation state of the donor group (the side chain group that binds the coupling
ion) might facilitate interactions between NorM-PS and Na+, and hence, might convert a
H+-coupled system to a Na+-coupled one.
Fig. 3.5 The ethidium export activity of NorM-PS at acidic and basic pH values. In L. lactis
cells under acidic conditions, ∆p largely consists of ∆pH (see Fig. 4.2) and hence a significant
export activity is seen. At basic pH (pHin=pHout), ∆p is largely composed of ∆ψ , hence no
transport is observed in the presence of added K+.
NorM-PS remained exclusively H+-coupled at acidic, basic, or neutral pH values and no
stimulation by Na+ was observed. These results establish the specificity of H+-coupling in
NorM-PS and rule out the possibility that NorM-PS might utilise Na+ under proton-scarce
conditions.
40 Different ion-coupling requirements of NorM-VC and NorM-PS
3.3 The Na+-dependent ethidium transport by NorM-VC
To study the dose-response relationship between the extracellular concentration of Na+ and
NorM-VC-mediated ethidium efflux rates, the NorM-VC expressing L. lactis cells were de-
energised and resuspended in K+-free Tris-Cl buffer (pH 7) supplemented with 5 mM MgSO4.
After loading the cells with ethidium , glucose was added as a source of metabolic energy
and increasing amounts of Na+ (Na2SO2) were added along with the glucose. Ethidium
efflux by NorM-VC was stimulated in presence of Na+. The stimulation was observed at
Na+ concentrations as low as 50 µM, until a saturation phase was reached at concentrations
around 10 mM.
Fig. 3.6 a, In the absence of ∆p, NorM-VC can export ethidium in a Na+-dose dependent
manner. The NorM-VC expressing cells showed efflux in presence of as low as 50 µM Na+.
The stimulation by Na+ saturated in the mM range of concentrations. b , The ethidium export
rate (∆fluorescence/time) is plotted against the Na+ concentration, and is fitted to a hyperbole.
N=3 from independent studies.
To determine the apparent Na+-binding affinity of NorM-VC in the cells, the rate of
ethidium efflux was calculated between the first 100-250 seconds by dividing the change in
fluorescence by time. The ethidium export rates were plotted against the Na+ concentrations
and fitted to a hyperbole using GraphPad Prism. The apparent transport constant (Kt) for Na+
was 393 ± 61 µM which is comparable to values reported previously [34].
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3.4 Na+-binding improves ethidium-binding to purified NorM-
VC but not to NorM-PS
Ethidium export assays in live bacterial cells simulate the most biologically-relevant scenario,
however they also suffer with issues such as background signal by non-specific cellular
proteins. To address these issues, purified NorM (VC and PS) proteins were used to test: a)
their ethidium binding properties, and, b) the effect of metal-ions on the ethdium-binding to
proteins. The proteins were purified from inside-out membrane vesicles using Ni+-affinity
chromatography. Equal amounts of proteins were diluted in assay buffer and the ethidium
binding was monitored by measuring fluorescence anisotropy. Fluorescence anisotropy
occurs when a fluorophore emits light of unequal intensities along different axes of polarisa-
tion. Hence when a small fluorophore binds a macromolecule the fluorescence anisotropy
increases and the increase in anisotropy can be used to quantify the binding.
To study ethidium binding, the proteins were added in a stepwise manner to a buffer
containing a fixed concentration of ethidium bromide. Na2SO4 was added where required.
The results suggested that purified NorM-VC and NorM-PS bind ethidium in a concentration
dependent manner (Kd= 0.56 ± 0.04 µM and 1.01 ± 0.09 µM, respectively). NorM-VC
binds ethidium with a higher affinity compared to NorM-PS. The addition of 1 mM Na+
leads to a ∼10-fold increase in the binding affinity of NorM-VC (Kd value of 0.06±0.01
µM) but in unaltered binding for NorM-PS (Kd=0.78 ± 0.09 µM).
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Fig. 3.7 a, Purified NorM-PS and b, NorM-VC proteins bind ethidium in a dose-dependent
manner (fixed ethidium and varying protein concentrations). Upon addition of 1 mM Na+ to
the assay buffer, the affinity of NorM-VC for ethidium increases. NorM-PS shows no such
stimulation upon additions of Na+. The elution buffer was used as control to generate the
baseline. N=3 (independent studies).
These data are in agreement with the ethidium efflux studies in intact cells. Evidently,
the two highly similar proteins differ in their Na+ binding behavior. It raises two questions:
what are the structural features that entail this difference? And what is the biological (and
evolutionary) context of this difference? In the following section, the first question will be
explored further.
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3.5 NorM-VC and NorM-PS give rise to transport-active
chimeric transporters
3.5.1 Construction of chimeric transporters
In order to look for structural differences in NorM-VC and NorM-PS that might be responsible
for their ion preferences, further studies on the Na+-binding site(s) are required. The crystal
structure of NorM-VC has Rb+/Cs+ bound at the C-lobe (near the E255/D373 centre) [29], but
previously the mutagenesis data had suggested that the N174A mutation in NorM-VC leads
to a 1200-fold drop in the binding affinity for Na+ [34]. These two sites are in two different
lobes in the published crystal structure of NorM-VC (PDB IDs 3MKT and 3MKU) and seem
to be far apart in the outward-facing conformation in which NorM-VC was crystallised.
Fig. 3.8 NorM-VC crystallised with Rb+ (PDB ID 3MKT). a, In the crystal structure, the Na+
analogue binds in the C-lobe (shown as golden), whereas N174A mutation in N-lobe (shown
as cyan) causes a drastic drop in affinity for Na+. The distance between these two locations
is very large (about 23 angstroms). b, Same structure seen from a 90◦angle (top view).
44 Different ion-coupling requirements of NorM-VC and NorM-PS
To dissect whether the Na+-binding site is in the C-lobe or in the N-lobe, a set of chimeric
proteins from NorM-VC and NorM-PS was made. The reasoning behind this was to swap the
N- and C-lobes of NorM-VC and NorM-PS to create two different chimeric proteins. The ion
dependence of the resulting chimeric proteins could indicate the location of the Na+-binding
site in NorM-VC.The overall experiment and the hypothesis are summarised in the flow chart
below:
Fig. 3.9 A brief schematic of the overall design of chimeric NorM proteins.
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The chimeras were constructed using the FastCloning method as described in Chapter
2 section 2.5. The genes were cloned in the pNZ8048 vector and L. lactis cells were
transformed with the resulting vectors. The NorM-VC(NL)-NorM-PS(CL) chimera was
constructed by fusing the NorM-VC residues 1-225 with NorM-PS residues 227-464 and the
NorM-PS(NL)-NorM-VC(CL) chimera was constructed by fusing the NorM-PS residues
1-227 with NorM-VC residues 226-461. Analyses by western blots showed that the chimeric
proteins expressed equally well in the plasma membrane of the lactococcal cells.
Fig. 3.10 Anti-His immunoblot showing the expression of NorM-VC, NorM-PS and the
chimeric proteins. 2 µg of total membrane proteins was loaded onto each lane. Besides
the primary bands, the NorM-VC and NorM-VC(NL-D36N)NorM-PS(CL) chimera show
a secondary band consistent with the size of a dimer. NorM-PS and chimeras containing
the CL part of NorM-PS show a smaller molecular weight band which might be due to
intramolecular cross-linking between the two closely located cysteins in the C-lobe or due to
enhanced SDS binding.
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3.5.2 The NorM chimeric transporters transport ethidium in strictly
proton-coupled and electroneutral manner
The cells expressing the chimeric transporters were tested for their transport activities in
ethidium export assays. Both the chimeric transporters were found to be transport-active
compared to the chimeric transporters containing the inactivating D36N point mutation in
the chimera containing N-lobe of NorM-VC.
Fig. 3.11 a, The chimeric transporters exhibit significant ethidium export compared to the
inactive chimeric mutant (containing NorM-VC (NL) D36N). b, The bar chart shows mean
(±SD) end levels of ethidium fluorescence after export. N=3 (independent studies).
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However, when Na+ was provided alongside glucose, neither of the chimeric transporters
showed any response to millimolar concentrations of extracellular Na+.
Fig. 3.12 a, The chimeric transporters show no Na+-dependent stimulation of ethidium
transport. The traces shown here are those closest to the mean value of replicates. b, The
bar chart shows mean (±SD) end levels of ethidium fluorescence after extrusion. N=3
(independent studies).
To corroborate these findings, the effect of Na+ on ethidium-binding to the purified
chimeric proteins was measured using fluorescence anisotropy. The purified chimeric
proteins exhibited no stimulation in ethidium binding in presence of Na+, confirming
the loss of Na+-binding site(s) or allosteric interaction. Interestingly the chimera NorM-
VC(NL)NorM-PS(CL) displayed ethidium binding akin to that of NorM-VC (Kd=0.01137
µM) and the chimera NorM-PS(NL)NorM-VC(CL) showed ethidium binding similar to
NorM-PS (Kd=0.1221 µM). The difference in the Kd values of ethidium binding to the two
chimeras was statistically significant (P value < 0.0001). This might suggest that the ethidium
binding site in both NorM-VC and NorM-PS is in the N-lobe.
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Fig. 3.13 Ethidium binding to purified chimeric transporters, a, NorM-VC(NL)NorM-PS(CL),
and b, NorM-PS(NL)NorM-VC(CL) measured by fluorescence anisotropy. Neither of
the chimeric transporters show the Na+-dependent enhancement of ethidium binding as is
observed for NorM-WT. Increasing amounts of the purified chimeric proteins were added to
the assay buffer containing 2 µM ethidium in the absence or presence of 1 mM Na+. The
elution buffer was used to generate baseline (control). N=3 (independent studies).
The loss of Na+-coupling in the chimeric transporters indicates that the Na+-coupling
mechanism in NorM-VC employs both the N-lobe and C-lobe, and, that this mechanism is
completely lost upon replacement of either lobe by those of H+-coupled NorM-PS. To ensure
that the loss of Na+-coupling was due to the complete disruption of the Na+-binding site
and not due to a shift in ion-specificity, the ethidium export assay was carried out at pH ∼8.
At this pH, the relative concentration of Na+ ions relative to protons will be higher and a
promiscuous ion-binging site might then preferentially bind Na+.
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Fig. 3.14 At pH 8, the ∆p- dependent transport activity of the chimeric transporters is
disrupted. Furthermore, addition of Na+ does not cause any stimulation of the transport
activity. a, the traces shown are those nearest to the mean value of the replicates. b, The
bar chart shows mean (±SD) end levels of ethidium fluorescence after extrusion. N=3
(independent studies).
At a raised pH, the chimeric transporters elicited highly reduced activity relative to
activity at neutral pH. When pHout=pHin, the ∆p almost entirely consists of ∆ψ . The absence
of transport at high ∆ψ values indicates that there is no correlation between membrane
potential and ethidium transport mediated by the chimeric transporters. Furthermore, the
chimeras did not show any Na+-dependent ethidium transport even at an elevated pH.
Previously, NorM-VC was shown to transport ethidium in an electrogenic manner [34],
which is a consequence of the exchange of two (or more) coupling-cations per ethidium
molecule. To test whether the chimeras transport ethidium in an electrogenic manner too, the
ethidium export assay was conducted while selectively abolishing the different components
of ∆p using ionophores. Nigericin , a H+/K+ exchanger, was used to selectively dissipate
the ∆pH. Whereas, valinomycin, a K+ carrier, was used to selectively dissipate the ∆ψ . A
combination of these two ionophores dissipates the ∆p completely. If the chimeric proteins
transport ethidium in an electrogenic manner, there should still be a net movement of ethidium
in presence of the ∆ψ only.
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Fig. 3.15 The chimeric transporters a, NorM-PS(NL)NorM-VC(CL), and b, NorM-
VC(NL)NorM-PS(CL) extrude ethidium in a ∆pH-dependent, electroneutral fashion. The
control shown here is the ethidium transport without ∆p. In the presence of ∆ψ only, no
transport takes place, indicating the electroneutral nature of the transport reaction. c, The bar
chart shows mean (±SD) ethidium end levels. N=3 (independent studies).
In the whole cell assays, the chimeras appear to transport in an electroneutral manner, i.e.,
no ethidium transport was seen when only ∆ψ was provided indicating that only one H+ was
being antiported per molecule of ethdium. This is different from the transport stoichiometry
of NorM-VC which has been shown to transport in presence of ∆ψ only.
3.6 Structural considerations and a potential mechanism
for transport-active chimeras
It is remarkable that two different MATE transporters sharing only 42% identity should give
rise to functional proteins upon domain swapping. One would expect that these proteins
must have highly conserved residues at sites where the two lobes make contact, however
this is not apparent at the amino acid sequence level. Also, in absence of a 3D structure for
NorM-PS, it becomes difficult to postulate with certainty which structural elements NorM-
VC and NorM-PS might have in common. However, a potential explanation can be given
by considering the structures of pfMATEPyrococcus furiosus and AtDTX14Arabidopsis thaliana. In
pfMATE, two carboxylates in the N- lobe (D41TMH1 and D184TMH5) form the proton-binding
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site. Upon protonation of D41, a rearrangement of hydrogen-bond network leads to bending
of TM1 at G30. Such an event possibly causes switching from an outward-facing state to
an inward-facing state. Interestingly, the AtDTX14 structure suggests a similar mechanism,
except that the switch happens in TMH7 - protonation at E265/D383 leads to helix bending
at G255. Furthermore, both pfMATE and AtDTX14 do not have any consensus carboxylates
in C-lobes and N-lobes, respectively. These two proteins seem to be ‘mirror images’ of each
other, suggesting that MATE transporters evolved via a gene duplication event. A comparison
of the two structures reveals a pseudo two-fold symmetry.
Fig. 3.16 Pseudo two-fold symmetry between a, the eukaryotic MATE transporters AtDTX14
and b the archael MATE transporter pfMATE. The N-lobe of pfMATE looks like the C-lobe
of the A. thaliana transporter. The two proteins have a common mechanism of transport
which is that protonation at one of the two closely placed carboxylates leads to bending of a
helix leading to the inward-open state.
To look for such internal symmetry in NorM-VC, the X-ray structure (PDB ID: 3MKU)
was analysed using the online tool TM-align [52]. The N- and C-lobes were compared to
each other via structural alignment. On a scale of 0 to 1 (a score of 0.5 - 1.0 indicates the same
SCOP (Structural Classification of Proteins) fold. The N- and C-lobe belonging to the same
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SCOP fold would indicate existence of a two-fold internal symmetry. Upon such analysis,
NorM-VC scores a TM-align value of ∼0.8. Similar values were found when the N-lobe
of NorM-VC was structurally aligned to the C-lobe of pfMATE (and vice versa). Table 3.1
lists the structural alignment comparisons scores between N- and C-lobes of different MATE
transporters.
Table 3.1 Internal-symmetry scores for MATE transporters
PDB IDs Protein and lobe name TM-align score
3MKU, 3MKU NorM-VC (N) NorM-VC (C) ∼0.8
3MKU, 3VVN NorM-VC (N) pfMATE (C) >0.8
3MKU, 3VVN NorM-VC (C) pfMATE (N) ∼0.8
5Y50, 3VVN AtDTX14 (N) pfMATE (C) >0.8
5Y50, 3VVN AtDTX14 (C) pfMATE (N) ∼0.8
The symmetry between eukaryotic AtDTX14 and archaeal pfMATE indicates the conser-
vation of structural folds across taxonomically distinct species. With such information, it
would not be presumptuous to think that NorM-PS will also have these conserved domains
and in such case, swapping its domains with those in NorM-VC can result in a protein that
has high similarity with the wildtype parent proteins. The concept of such internal symmetry
and repeat units has been reported in several transporters and the phenomenon has been
utilised to explain the mechanism of transport [53], [54]. Such mechanism could provide a
universal mode of transport for MATE proteins and requires extensive computational studies
and empirical validation. Despite these speculations, it is still difficult to state why the
chimeric transporters discussed here are not Na+ responsive. The coordination of Na+ is a
multicomponent event and hence the Na+-binding elements in proteins might be sensitive to
small structural changes. In contrast, in order to interact with H+, only a strategically placed
acidic residue (with an optimum pKa value) is required. Such flexibility in rearrangement
of active carboxylate has been demonstrated in the H+-coupled MFS family transporter,
LmrP [55]. In LmrP, the active carboxylate could be placed one helical turn away and the
resulting protein retains its H+-coupled ethidium transport activity. It has been shown that as
a compensatory mechanism, sodium translocating systems can translocate H+ in the absence
of sodium gradients[56], but the reverse might not always be true. Perhaps this is why the
chimeras retain H+-coupling but lose Na+-coupling. The Na+-binding sites in NorM-VC and
the potential to form a Na+-binding site in NorM-PS are discussed in Chapter 5.
Chapter 4
The pH dependence of Na+-coupled
ethidium transport by NorM-VC
In this chapter, the preferential use of protons and sodium-ions by NorM-PS and NorM-VC
was studied with respect to (i) the altered composition and magnitude of the ∆p , i.e. ∆pH
and ∆ψ , and (ii) the relative availability of H+ versus Na+ (∆pH and ∆pNa).
The energetics of ethidium transport by NorM-PS and NorM-VC was studied by using
ionophores that selectively dissipate the components of the ∆p . The ionophore nigericin
mediates K+/H+ antiport and dissipates the ∆pH in an electroneutral manner. Valinomycin
acts as a mobile carrier of K+ and dissipates the ∆ψ . In the presence of nigericin, the ∆p is
solely composed of ∆ψ , whereas in the presence of valinomycin the ∆p is entirely composed
of ∆pH. A combination of both the ionophores will completely dissipate the proton motive
force and no ∆p-dependent substrate transport will take place. In these experiments, ethidium
serves as an ideal substrate as the ionisation state of ethidium does not change between pH 6
to 9 (the range of pHs used here). The pKb values of the two ionisable amines in ethidium
have been experimentally determined to be 0.8 and 2 [57], thus eliminating the possibility of
proton transport through ethidium binding. For ethidium transport assays, MATE expressing
cells (non-expressing cells as negative control) were de-energised using the protonophore
DNP and resuspended in KPi buffer (with different pH values) supplemented with MgSO4.
The cells were preloaded with ethidium bromide after which glucose was added (with or
without 1 mM Na+ in case of NorM-VC). To dissipate the components of ∆p selectively,
the ethidium-loaded cells were incubated with 0.5 µM of nigericin or valinomycin for two
minutes before the addition of glucose. The same assay was performed at pH 6, 7, and 8.
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4.1 NorM-PS mediated ethidium transport is exclusively
∆pH driven
NorM-PS was previously shown to be H+-coupled in transport studies in E. coli [42] and
based on these transport models have been proposed [58]. However, the transport assay
employed in these studies suffers from the drawback that it does not directly measure
drug transport itself but instead relied on pH-indicating fluorophore acridine orange, which
presumably reports drug-proton antiport by NorM-PS in inside-out membrane vesicles. The
change in the internal pH in these membrane vesicles does not necessarily originate from
drug-proton antiport, but could also be the result of a combination of other factors such as
proton pumping by non-specific proteins. The ethidium transport assay employed in my
study is more accurate as this assay reports the intracellular concentration of ethidium by
measuring the fluorescence of ethidium-nucleic acids complex. Ethidium in this complex
shows 10 times more fluorescence emission than free ethidium in aqueous solution. Along
with the reversible nature of the ethidium-nucleic acid binding, these properties of ethidium
make this assay more accurate.
The ethidium transport in L. lactis cells was measured at pH 6, 7 and 8 under conditions
where the cells were allowed to generate proton motive force (∆p), proton gradient only
(∆pH), membrane potential only (∆ψ) and no ∆p (control). As shown in Figure 4.1, NorM-PS
expressed in L. lactis mediates ethidium export by exclusively coupling to proton gradient at
pH 6, 7 and 8. Consistent with the observations in Chapter 3, no major correlation between
membrane potential and ethidium transport was observed, thus establishing the important role
of ∆pH as a driving force for NorM-PS mediated transport and the electroneutral nature of
the overall transport reaction. Upon addition of glucose, cells regain their metabolic activity
and as a result the cell interior becomes alkaline and negatively charged and a sudden influx
of positively charged ethidium is seen in cells that lack NorM-PS-dependent efflux activity.
As ethidium bears a single positive charge at these pH values, NorM-PS must mediate the
antiport of one H+ per ethidium molecule to maintain electroneutrality in these experiments.
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Fig. 4.1 The NorM-PS expressing L. lactis cells export ethidium in a ∆pH-dependent and
electroneutral manner at a, pH 6, b, pH 7, and c, pH 8. The NorM-PS mediated efflux
diminishes with increasing alkalinity. The traces shown on the left are normalised for the
initial fluorescence levels and are representative of the mean of the triplicates. The bar chart
shows mean (±SD) end levels of ethidium fluorescence after export. N=3 (independent
studies).
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4.2 Increased alkalinity makes NorM-VC mediated ethid-
ium transport electrogenic
To correlate NorM-VC mediated ethidium export with components of the ∆p, the ethidium
export assay in non-expressing (8048) cells and NorM-VC expressing cells was performed at
different pHs in the absence or presence of ionophores. To better interpret the results, the
magnitude of the components of ∆p was measured using the lipophilic cationic membrane
potential probe DiOC2(3). The cells used in the transport assays were energised with glucose
and loaded with the probe DiOC2(3). The accumulation of DiOC2(3) in the cells is indicated
by an increase in the red fluorescence (620 nm), with increasing ∆ψ . Upon addition of
nigericin, the cellular ∆pH is converted into ∆ψ and an increase in red fluorescence is seen.
Further addition of valinomycin dissipates the ∆ψ which dissipates the total ∆p. In these
experiments, NorM-VC-expressing cells exhibited lower levels of DiOC2(3) accumulation
than the non-expressing control. This might be due to the NorM-VC-mediated export of
DiOC2(3) and it might be more useful to consider the DiOC2(3) responses in the non-
expressing cells. The possible export of DiOC2(3) by NorM-VC can be be investigated n the
future studies.
As shown in Figure 4.2, at pH 6, the ∆p in L. lactis cells is entirely composed of ∆pH
with almost no contribution from the ∆ψ . Consequently, the addition of valinomycin has
little effect, and the ethidium export activity is fully retained. Upon the addition of nigericin,
no ethidium export is seen suggesting that at pH 6, NorM-VC is biased towards the ∆pH.
Interestingly, in the presence of 1 mM Na+, NorM-VC showed enhanced ethidium extrusion
(Figure 4.2 b).
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Fig. 4.2 a, At pH6, the NorM-VC expressing L. lactis cells export ethidium efficiently when
compared with non-expressing control (8048) cells. The traces shown here are normalised
for the initial fluorescence level and are representative of the mean of the triplicates. The
bar chart next to the traces shows end mean (±SD) levels of ethidium fluorescence levels in
8048 cells (no pattern) and NorM-VC cells (ribbed). b, Same as a except Na+ was provided
alongside glucose. c, The ∆ψ measurements in NorM-VC(red) and control cells (black)
show that at pH 6 (± Na+) the ∆p is entirely composed of ∆pH. d, same as c, except Na+ was
provided. N=3 (independent studies).
At pH 7, the ∆p has contributions from the ∆ψ and the ∆pH, which are utilised by
NorM-VC to export ethidium. NorM-VC expressing cells show reduced levels of ethidium
accumulation in presence of the ∆ψ only, as compared with the control (Figure 3a) indicating
antiport of two ions (2H+, or 1H+ plus 1Na+) per ethidium. However, upon addition of 1 mM
Na+ (Figure 4.3b), this ∆ψ-dependent extrusion does not improve in a NorM-VC specific
manner indicating that Na+ might not take part in the antiport reaction under these conditions.
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Fig. 4.3 a, At pH 7, NorM-VC-mediated ethidium transport becomes electrogenic with
contributions from the ∆pH and the ∆ψ . The traces shown here are normalised for the initial
fluorescence level and are representative of the mean of the triplicates. The bar chart next to
the traces show the end mean (±SD) levels of ethidium fluorescence levels in 8048 cells (no
pattern) and NorM-VC cells (ribbed). b, Same as a except sodium was provided alongside
glucose. c, The ∆ψ measurements in NorM-VC (red) and control cells (black) show that
at pH 7 (± Na+) the ∆p has contributions from ∆pH and ∆ψ . d, same as c except Na+ was
provided. N=3 (independent studies).
4.3 Proton scarcity drives NorM-VC to switch to a ∆pH-
independent, Na+-coupled ethidium transport reaction
At pH 8, pHout approaches the pHin in cells, and hence, the ∆pH is close to 0. The ∆p is
therefore mainly composed of the ∆ψ (Fig. 3A). In agreement with this, the NorM-VC
mediated extrusion of ethidium is driven by the ∆ψ . However, in the presence of valinomycin
(∆p = delta pH), NorM-VC also exhibits activity. Thus, similar to the results for pH 7.0, the
efflux can be coupled to both components of the ∆p (the ∆pH and the ∆ψ). The addition
of Na+ enhances the ∆p-dependent export, and interestingly, NorM-VC is able to couple
ethidium extrusion to ∆pNa even upon complete dissipation of the ∆p (Fig. 4.4). Thus, with
the reduced availability of protons, NorM-VC can switch to a ∆pH-independent Na+-coupled
ethidium transport reaction.
This observation becomes relevant upon considering the habitat of Vibrio cholerae (VC).
One of the biggest reservoirs of V. cholera are estuaries where the pH and salinity of the
water varies between neutral and fresh to alkaline and saline. Hence, it would be beneficial
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Fig. 4.4 a, At pH8, the NorM-VC-mediated ethidium export can be driven by ∆ψ . b, In the
presence of Na+, NorM-VC can couple ethidium to ∆pNa exclusively. The traces shown
here are normalised for the initial fluorescence level and are representative of the mean of
the triplicates. The bar chart next to the traces show end mean (±SD) levels of ethidium
fluorescence levels in 8048 cells (no pattern) and NorM-VC cells (ribbed). c, The ∆ψ
measurements in NorM-VC (red) and control cells (black) show that at pH 8 (±Na+) the ∆p is
largely composed of ∆ψ . d, same as c except Na+ was provided. N=3 (independent studies).
for the survival of the organism to utilise a transport system that can couple to ∆pH at neutral
(or slightly acidic) pH and couple to the ∆pNa at alkaline pH values.
Similar effects of pH on the Na+-dependent stimulation of enzyme activity have been
observed for BCl-MotAB flagellar motor complexes [59]. BCl-MotAB was shown to utilise
H+ at neutral pH but Na+ at alkaline pH. How these systems fine-tune their ion-binding and
transport properties with the environment is fascinating and requires further investigations.
4.4 Increasing alkalinity promotes ethidium binding to NorM-
VC
To assess the relationship between the NorM-VC-mediated ethidium transport and the pH, the
ethidium binding to NorM-VC and associated mutants was tested by the means fluorescence
anisotropy measurements. Previously, sequence analysis and biochemical studies have
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identified three critical carboxylate residues (D36, E255 and D371) in NorM-VC. The amide
mutants at these positions were used as controls since the amide moiety is basic in nature
and mimics their protonated carboxylate counterparts.
Fig. 4.5 Ethidium binding to purified NorM-VC and mutant proteins at varying buffer pHs.
Ethidium binding to NorM-VC WT is promoted as the pH is raised. The D36N and E255Q
mutants didn’t exhibit any changes in ethidium binding with changes in pH and acted like
control (elution buffer). The D371N mutant retains some of the pH dependency of the wild
type protein. N=3 (independent studies).
As seen in the Figure 4.5, purified NorM-VC binds increasing amounts of ethidium
as the pH of the buffer increases – there is about a 2-fold increase in anisotropy at pH 9
compared with the anisotropy at neutral pH. This indicates competition between ethidium and
H+ binding to NorM-VC and is consistent with the previous reports [34] where NorM-VC
was shown to release H+ upon ethidium-binding. Also, D371N is the only mutation that
partially retains the pH-dependent ethidium binding. The two other amide mutants, D36N
and E255Q, show no correlation between pH and ethidium binding, pointing towards the
importance of ionisable carboxylate groups at these positions for pH-sensitive ethidium
binding to NorM-VC.
To explore how the pKa values of different carboxylates vary upon the outward-open to
inward-open conformational switch in NorM-VC, an inward-open homology model of NorM-
VC was built by using the structure of the MOP flippase, MurJ (PDB ID: 5T77). A homology
model with Qmean of -6.38 was generated using the online server SWISS-MODEL. Figure
4.6 shows a cartoons of the model as seen in different orientations.
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Fig. 4.6 The MurJ-based inward-open homology model of NorM-VC. N-lobe shown as green
and C-lobe shown as golden yellow. a, The opening of the intracellular interface can be seen.
The same structure as seen from the intracellular side b, and extracellular side c. The extreme
bending of the E255 harbouring TMH7 is evident. The distance between E255 and D371
increases by 5 Å compared with that in outward-open crystal structure (PDB ID 3MKT).
This might be due to the repulsion caused by deprotonation of these residues upon exposure
to the alkaline cell interior.
The outward-open crystal structure of NorM-VC (PDB ID: 3MKU) and the inward-open
homology model of NorM-VC were used to calculate the pKa values of the carboxylates
using the online server H++ [60]. All the parameters were kept to their default values. The
predicted pKa values are listed in Table 4.1.
Interestingly, D371 shows a drastic change in the protonation state between the outward-
open and inward-open conformations (∆pKa= 4.2) which further strengthens the possibility
that protonation of D371 can trigger the switch from the outward-open state to the inward-
open state and that the release of this proton perhaps leads to the binding of ethidium in the
inward-open conformation.
The results presented in this chapter establish fundamental differences between the
mechanisms of energy coupling in NorM-PS and NorM-VC. Whereas NorM-PS couples
to protons exclusively and antiports one H+ per ethidium molecule, NorM-VC carries out
H+-coupled electroneutral transport at acidic pH, but H+- and Na+-coupled electrogenic
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Table 4.1 A comparative list of the pka values of NorM-VC carboxylates
Residues pKa in outward-facing pKa in inward-facing




ethidium-transport at basic pH. Furthermore, the observation that the binding of ethidium to
purified NorM-VC is promoted at alkaline pH points toward the importance of deprotonation
of at least one of the three conserved carboxylates (D36, E255, and/or D371). The binding
studies with amide mutants corroborate the latter hypothesis as D36N and E255Q completely
lose the pH-dependence of ethidium binding, whereas the effect of D371N is significant but
less dramatic.
Chapter 5
Towards altering the coupling-ion
requirements of MATE transporters
The Na+-binding sites in proteins are elusive – partly due to the versatile coordination
chemistry of Na+ and the chemically diverse coordinating side-chains in proteins. Na+ can
interact with proteins in strikingly diverse ways. Besides the main chain carbonyl oxygen,
common side-groups that can bind Na+ are provided by carboxylate, amide and hydroxyl
group containing amino acids. However, at times, aromatic residues can also interact with Na+
via pi-cation interactions. Furthermore, ordered water molecules can be part of a Na+-binding
site. Na+ usually binds proteins with a coordination number that varies from 5 to 6 (rarely 4
or 7) and the ideal coordination geometry can be octahedral for a coordination number of
6, trigonal bipyramid or tetragonal pyramid for a coordination number of 5, and tetrahedral
or square planar for a coordination number of 4 (see Figure 5.1). Such a diversity in terms
of the nature of donor groups and coordination numbers (and coordination geometries) can
in principle allow many different modes of Na+-binding to proteins. This is partly why
Na+-binding sites in proteins are difficult to generalise and predict. In this chapter the
cation-binding sites in NorM-VC have been dissected using structural and mutational studies,
and the information has been used to study the effect of mutations on the ion-requirements of
NorM-PS.
5.1 A comparative account of the Cs+/Rb+-binding site in
NorM-VC and its structural counterpart in NorM-PS
Based on the X-ray crystal structure of NorM-VC and the previous biochemical studies and
the studies included in this thesis, NorM-VC seems to have two ‘Na+-binding hotspots’ –
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Fig. 5.1 The ideal coordination geometries for Na+: a, octahedral for coordination number
6, b, trigonal bipyramidal or c, tetragonal pyramidal for coordination number 5, and d,
tetrahedral or square planar for coordination number 4. L=ligand (donor group).
regions in the tertiary structure that are involved in Na+ binding and transport. In the 3D
structure, these hotspots are centred around three carboxylates, which are D36 in the N-lobe
(close to N174) and the E255/D371-dyad in the C-lobe (close to F429 and Y369). The high
level of amino acid sequence conservation between NorM-VC and NorM-PS at the ‘transport
hotspots’ provides an excellent opportunity to compare the amino acid sequence variation
that might be responsible for the differences in their ion-coupling behaviours. Figure 5.2
depicts a sequence alignment between NorM-VC and NorM-PS highlighting the conservation
(underlined by black bars) at sites important for transport activity.
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Fig. 5.2 Amino acid sequence alignment of NorM-VC (PDB ID 3MKT) and NorM-PS
(GenBank ID EHY79494.1) shows a high level of conservation ( conserved residues shown
in white against red background) at the regions important for transport (underlined by black
bars). Notably, the transmembrane regions (shown as springs) are more conserved than
the connecting loops. The indicated helices are based on the NorM-VC structure (PDB ID:
3MKT). Alignment performed using Prabi ClustalW and figure generated using ESPript 3.0.
NorM-VC was co-crystallized with Rb+ bound in the C-lobe (PDB ID: 3MKU), which
was suggested to act as a Na+ analogue. A quick survey of the Rb+-binding site in this
structure shows that the Rb+ is in close proximity to three residues, namely F259, Y369 and
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F429 (all within 4 Å). The carboxylates E255 and D371 are further away ( 6 Å or more); it is
likely that the situation is different under physiological conditions where water molecules
mediate the interactions between the distal metal ion and the carboxylates. Although E255
and D371 are also conserved in NorM-PS (E257NorM-PS and D373NorM-PS), my experiments
demonstrate that NorM-PS does not utilize Na+-cycling. This raises the question whether
there are any residues missing in NorM-PS that would enable Na+-binding in this location.
In the experiments presented here, I therefore focused on the surrounding residues in the
Rb+-binding pocket of NorM-VC that are different in NorM-PS.
Fig. 5.3 a, The crystal structure of NorM-VC. The Rb+-binding pocket is shown in the
rectangle. b, The Rb+ binding site in NorM-VC (3MKT) is shown. The three closest
interaction distances are observed for F259, Y367 and F429. The carboxylate E255 and
D371 are further away and might be differently positioned under physiological conditions, or
might require a structural water molecule to coordinate the metal-ion.
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Table 5.1 lists the residues that are believed to be important for drug/ion antiport in
NorM-VC and NorM-PS.
Table 5.1 Residues important for drug/cation antiport in NorM-VC and NorM-PS
NorM-VC NorM-PS Relevance (putative)
in NorM-VC
D36 D38 Cs+/Rb+-binding and
perhaps structural maintenance
E255 E257 H+/Na+ binding and transport (empirical)
D371 D373 Rb+-binding
N174 N176 Involved in Na+-binding (empirical)
F259 F261 Contributes to Cs+/Rb+-binding site
Y367 F369 Contributes to Cs+/Rb+-binding site and perhaps
the most important endogenous
coordinating ligand for metal-ion binding
F429 L430 Contributes to Cs+/Rb+-binding site
S199 A201 Within H-bonding distance from D36
Interestingly, the pKa of D371NorM-VC is predicted to be significantly affected by Y367NorM-VC
(calculated using the online server H++). Furthermore, the oxygen atom of Y367 hydroxyl
group is in close proximity to Rb+/Cs+, indicating its probable involvement in the metal-ion
binding. Table 5.2 lists imporatnt residues that are predicted to contribute to the pKa of
D371NorM-VC.
Table 5.2 Residues affecting the pKa of D371
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In addition to mutations in the C-lobe , the N174ANorM-VC mutation near D36 in the
N-lobe is known to cause a drastic drop in the binding affinity for Na+ [34]. This observation
is supported by computational studies which predict the involvement of D36 in sodium
movement through the protein [40]. Hence, it becomes important to also examine the
differences in the D36-region between NorM-VC and NorM-PS. D36NorM-VC is surrounded
by several polar amino acids (Figure 5.4).
Fig. 5.4 Ala199NorM-VC closely approaches D36NorM-VC, and is substituted by S201 in NorM-
PS. It is likely that, by forming a H-bond, the serine residue raises the pka of the D38NorM-PS
and causes the carboxylate to behave differently than its counterpart D36NorM-VC.
All of the residues highlighted in Figure 5.4 are conserved in NorM-PS, with A199NorM-VC
as the only exception that is substituted by S200NorM-PS. The hydroxyl group of S200NorM-PS
is very likely to be within hydrogen binding distance from D38NorM-PS and could be a factor
in determining the ion-binding properties of NorM-PS. To test these hypotheses, a set of
point mutants of NorM-VC and NorM-PS was prepared.
5.2 Restoration of the NorM-VC-like cation-binding site
in NorM-PS does not alter the ion-coupling in NorM-
PS
In order to investigate the amino acids in NorM-VC that contribute to its ion-binding
properties, a range of rational ‘loss of function’ and ‘gain of function’ point mutations
were introduced in NorM-VC and NorM-PS, respectively. Upon introduction of these
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mutations, the mutant genes were subcloned and expressed in L. lactis cells. The ethidium
transport assay was employed to test whether the mutants had an altered ability to interact
with Na+.
The introduction of F429L in the C-lobe of NorM-VC did not significantly affect the
expression of the protein compared to the wild type protein (Figure 5.5).
Fig. 5.5 The NorM-VC F429L mutant expresses to a level comparable with that of the wild
type. 2 µg of total membrane protein was loaded onto each lane. The proteins were visualised
using anti-His immunodetection.
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In the ethidium transport assay (Figure 5.6), the F429L mutant was found to be transport-
active. However, unlike wild type NorM-VC wild type, the ethidium efflux by the mutant
was not stimulated by Na+, indicating the loss of Na+-binding in the mutant.
Fig. 5.6 F429 is a critical part of the Na+-binding site in NorM-VC. Substitution of this
aromatic residue by an aliphatic residue (leucine) causes loss of Na+-dependent stimulation of
ethidium export in whole cells. a, The traces shown are normalised for the initial fluorescence
levels and are representative of the mean of the triplicates. b, The bars show end (±SD)
ethidium fluorescence levels after extrusion without (no pattern) and with (ribbed) Na+. N=3
(independent studies).
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To confirm the involvement of F429NorM-VC in Na+-binding, the NorM-VC F429L mutant
protein was purified and the effect of Na+ on the ethidium binding to the purified protein was
tested in the fluorescence anisotropy assay.
Fig. 5.7 The F429L mutation causes loss of Na+-dependent stimulation of ethidium binding
to NorM-VC. A fixed concentration of ethidium was titrated with increasing concentrations
of purified NorM-VC. The fluorescence anisotropy was measured after each addition of
protein. Equal amounts of elution buffer were added to generate the baseline (control). N=3
(independent studies).
In the anisotropy binding experiments, the affinity of ethidium for NorM-VC F429L with
and without Na+ was found to be statistically insignificant (kd value=0.415 µM and 0.501
µM respectively). The loss of Na+-stimulated transport in NorM-VC F429L shows that
the Cs+/Rb+-binding site observed in the crystal structure [29], is physiologically relevant.
These results emphasise the importance of the contribution of aromatic residues in metal-ion
coordination, in addition to the commonly recognised charged- and polar-residues.
/sectionIntroduction of point mutations in NorM-PS
F429 was introduced at equivalent positions in NorM-PS (L426FNorM-PS and L430F
NorM-PS) to test whether the introduction of F429 in NorM-PS could make the transporter
Na+-responsive. Anti-His immunoblot showed that the mutants of NorM-PS used in this
study expressed in L. lactis membrane to levels comparable with that of NorM-PS wildtype.
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Fig. 5.8 Anti-His immunoblot showing the expression of NorM-PS mutants used in this study.
2 µg of total membrane protein was loaded onto each lane.
In ethidium efflux assay in whole cells, neither L430F nor L426F caused NorM-PS-
mediated ethidium transport to be stimulated by Na+.
Fig. 5.9 a Insertion of F430, or b, F426 , or c, a combination of both does not confer Na+-
sensitivity to NorM-PS. The mutants were tested using ethidium export assay in L. lactis
cells. The same control trace had been juxtaposed in all three graphs as all three results were
part of the same study.
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As previously mentioned, Y367NorM-VC interacts closely with the Cs+ bound in the
NorM-VC crystal structure, hence a F369Y mutation was introduced in NorM-PS and tested
for its ability to facilitate Na+-stimulated ethidium transport.
Fig. 5.10 a, The introduction of Y369 in NorM-PS does not confer any Na+-dependence in
ethidium export in whole cells. Notably, NorM-VC interacts with Cs+/Rb+ via the hydroxyl
group of Y367 and in the crystal structures this side-chain appears to be most important
endogenous ligand. b, No statistically significant enhancement of NorM-PS F369Y mediated
ethidium transport was seen upon addition of Na+. N=3 (independent studies).
As shown here, the F369Y mutation did not confer any significant Na+ sensitivity to
NorM-PS. This, combined with the information derived from L430F and L426F mutants,
indicated that the differences between NorM-VC and NorM-PS in the C-lobe Cs+/Rb+-
binding site alone are not responsible for the difference in the ion selectivity of these two
transporters. Therefore, I investigated whether the D36/N174NorM-VC region in the N-lobe
region could be could provide an explanation for the differences in Na+-dependence of
the two transporters. As mentioned earlier, D36NorM-VC (D38NorM-PS) is in close vicinity
to A199NorM-VC(S201NorM-PS), but the S200ANorM-PS substitution did not impose any Na+
dependence to NorM-PS-mediated transport.
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Fig. 5.11 The NorM-PS S201A mutant does not gain Na+-dependency. In the X-ray structure
of NorM-VC, A199 (counterpart of S202NorM-PS) approaches D36 closely and it might be
possible that in NorM-PS, S201 interacts with D38 too.
It can be speculated that if the Na+-binding and transport events in NorM-VC require
cooperation between the N- and C-lobe, then all of the above-mentioned mutations need to
be introduced simultaneously in order to enable NorM-PS to bind and transport Na+. To test
the effect of the incorporation of these mutations in the N-lobe and C-lobe simultaneously,
a triple point mutant was prepared and tested. As shown in Figure 11, a triple-mutant
containing the mutations in the N-lobe (S201A) and C-lobe (F369Y, L430F) did not gain
Na+-dependence in the ethidium transport assay.
Fig. 5.12 Simultaneous mutations in the N- and C-lobe of NorM-PS do not result in Na+-
dependence of ethidium transport in L. lactis cells. The mutations were introduced with the
objective of converting NorM-PS into a Na+ dependent transorter.
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The results shown here indicate that the Na+-binding and transport in NorM-VC could not
be transferred to NorM-PS through the introduction of a range of point mutations in the latter.
Perhaps some of the main chain atoms in NorM-VC have interactions that are not feasible
in NorM-PS due to differently oriented helices. With varying degrees of success, previous
studies have attempted to alter the Na+ versus H+ selectivity of membrane proteins. A Na+/K+
pump from human blood cells that mediates Na+/K+ exchange by hydrolysing ATP was
shown to mediate H+/K+ exchange reaction in absence of Na+, and Na+/H+ exchange in the
absence of K+ [61]. The C-ring of the bacterial f0/f1-ATP synthases is notably well studied
with regards to its promiscuity in H+ and Na+-coupling [62], and a range of hypotheses were
suggested with regards to the question how the amino acid composition of the ion-binding
site in the C-ring affects ion-selectivity. Furthermore, the flagellar motor system, BA-MotS,
that can couple to both Na+ and K+, was shown to become strictly Na+-coupled upon a single
mutation [63]. Similarly, the flagellar stator MotB from alkaliphilic Bacillus clausii, which
naturally has a promiscuous H+ or Na+-coupling behaviour, could be modified to couple to
either H+ or Na+ exclusively by introducing two point mutations [59]. However, in the case
of NorM-VC, the need for ion-coordination at the interface between two subunits and at
different locations along the translocation pathway could make the situation more complex.
It is not counter-intuitive that the number of mutations needed to alter the ion-specificity
(or promiscuity) might be higher than in case of a system with a single ion-binding site.
Furthermore, a more complex system is essentially more prone to disruption by mutations,
and hence makes the identification of gain-of-function mutations more difficult. The loss
of Na+ depedendence in chimeric transporters shown in Chapter 3 indicates towards the
same. Perhaps a high-throughput study would be more suitable to establish further structure-
function correlations between NorM-VC and NorM-PS.
5.3 ∆p or ∆pNa - which came first? An evolutionary co-
nundrum
It is interesting to consider the evolution of the Na+-dependent versus H+-dependent trans-
porters as it can provide insights into the question whether these two systems evolved
independently or whether one is a downstream product of the other (a result of environmental
demands). Also, another question is whether these systems are able to adopt each other’s
functionality. In other words, can a Na+-dependent system always become a H+-dependent
system (and vice versa) by point mutation(s) or domain swapping?
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From an evolutionary perspective, the primacy of one ion over the other has been a topic
of debate. The proton motive force (∆p) appears to be the primary intermediate for energy
conduction at present and is supported by the minimality of protonation as a chemical event.
The minimality of protonation could have favoured the evolution of H+-binding sites in
proteins (and other macromolecules). However, the conductivity of biological membranes
for H+ is several orders of magnitude higher than for Na+ [64]. This, combined with with the
abundance of Na+ in the prebiotic water (0.45 M NaCl), and the elevated temperature that
make lipid bilayers too permeable for H+, suggests that Na+-gradient might have been more
appropriate energy reservoir under these conditions.
Chapter 6
The pathway for Na+ movement through
NorM-VC
As described in Chapter 3, the Na+-dependent stimulation of NorM-VC-mediated ethidium
transport must involve both lobes of the transporter. Previously, molecular simulation and
biochemical studies have shown that Na+ binds in the D36 region and also near the E255/D371
dyad [40], [34]. A molecular simulation study predicted a physical cavity that acts as a
pathway for Na+-movement from the N-lobe to the C-lobe in NorM-VC in a parallel-lobed
protein conformation that looks very different from the outward-open V-shaped crystal
structure. To test that Na+ does indeed first bind at D36NorM-VC, ethidium export in NorM-
VC D36N expressing cells was tested under different pH values in the absence or presence
of ionophores and/or Na+. The assay was done similarly as described in Chapter 4 for
NorM-VC.
6.1 D36N mutation uncouples NorM-VC from Na+-dependent
ethidium transport
The ethidium export in NorM-VC D36N expressing cells (the immunoblot showing the
expression of this mutant is present in Chapter 3, Figure 9) was tested at pH 6, 7, and 8 with
or without 1 mM Na+. To test the effect of different components of the ∆p, the ionophores
nigericin or valinomycin were added to provide cells with ∆ψ only or ∆pH only, or no ∆p at
all (control). In these experiments NorM-VC D36N exhibited significant ethidium export
activity which was entirely dependent on the ∆pH. No activity was seen in presence of ∆ψ .
Also, the ∆p-dependent activity was the same as the ∆pH-dependent activity. In essence, the
electrogenic nature of the transport reaction was lost due to D36N mutation. Moreover, upon
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addition of 1 mM Na+, no enhancement of transport activity was seen. These results indicate
that for NorM-VC to couple ethidium transport to Na+, D36 is a critical residue.
Fig. 6.1 NorM-VC D36N transports ethidium in an exclusively ∆pH dependent and elec-
troneutral manner at pH 6, 7, and 8. At pH 8, unlike the wildtype, D36N mutant is not able
to couple to ∆pNa in absence of the ∆p. The traces shown here are closest to the mean value
of triplicates. The bar charts on the right show mean (±SD) end ethidium fluorescence levels
after extrusion. N=3 (independent studies).
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To test the effect of the D36N mutation on ethidium-binding behaviour of NorM-VC,
fluorescence anisotropy measurements with purified NorM-VC D36N protein were made.
The effect of Na+ was also tested by including 1 mM Na+ in the buffer.
Fig. 6.2 The D36N mutation in NorM-VC causes disruption of Na+-dependent stimulation
of ethidium binding. As shown in Figure 3.7b, wildtype NorM-VC exhibits a significantly
increased binding affinity for ethidium in the presence of Na+. However, the D36N mutation
leads to disruption of this stimulation in ethidium binding, indicating the importance of D36
in Na+-binding to NorM-VC. N=3 (independent studies).
The ethidium binding results indicate that NorM-VC D36N binds ethidium with an affinity
comparable to the wildtype without Na+(Kd =0.357 ± 0.056D36N $muMcomparedto0.5620.037wildtype$muM).
No improvement in affinity for ethidium was seen in the presence of Na+. On the contrary,
there was an apparent drop in affinity under these conditions (Kd+Na+= 0.811 ± 0.120
$muM).T heseresultsindicatethatwhileD36maynotbeaparto f theethidium−bindingsiteinNorM−
VC, itisaparto f aNa+−bindingsite.SinceD36isveryclosetotheextracellularterminuso f T MH1, itmightbeoneo f the f irstresiduescontactedbyextracellularNa+.
6.2 A novel (putative) Na+-binding site in NorM-VC
All structures of Na+-coupled MATE transporters to date show the transporters in outward-
open states, making it difficult to envisage how Na+ moves from the N-lobe (D36 region)
over to the C-lobe (E255/D371-dyad) in NorM-VC. In the outward-open crystal structure, the
distance between D36 and D371 is about 25 Å, which is too large for any type of interactions
to take place between the two residues. For the N-lobe to ‘hand-over’ the bound Na+ to
the C-lobe, the extracellular sides of the two lobes must come together - a configuration
possible in the inward-open state. A possible solution to this problem is an alternative protein
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conformation where the distance between the extracellular sides of the N- and C-lobes
becomes shorter. To visualise such a conformation, a homology model of NorM-VC were
prepared based on the MurJ crystal structure (described in Chapter 4). The MurJ-based
homology model helps to visualise the inward-open state of NorM-VC. Interestingly, E255
which is sequestered in the outward-facing crystal structure (solvent accessible area = 35.5
Å2) becomes relatively more solvent accessible in the MurJ based homology model (solvent
accessible area = 79 Å2). The exposure to the alkaline internal environment of the cell may
allow E255 to become deprotonated, a very important event in the transport cycle. The
solvent accessibility values were calculated using the online server Stride [65].
Fig. 6.3 Glu255NorM-VC is occluded in the outward-open state but becomes exposed to
internal alkaline environment of the cell in the inward-open state. a, The X-ray crystal
structure of NorM-VC (PDB ID: 3MKU). b, The MurJ-based homology model of NorM-VC.
N-lobe shown in cyan ribbon and C-lobe shown in golden. E255 is shown as spheres.
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In the NorM-VC crystal structure, D36 along with N174 and N178 might form a Na+-
binding site in the outward-open state. However, in the inward-open homology model, D36
(TMH1) and the two amides N174 and N178 (TMH5) move away from each other due to the
movement of TMH1 towards TMH8 in the C-lobe (see cartoon below). The proximity of
TMH1 and TMH8 is predicted to create a new Na+-binding site that involves D36 and the
Q278/N282-dyad at the extracellular side of the C-lobe. The distances between these two
centres are short enough to allow them to coordinate the binding of Na+.
Fig. 6.4 Formation of a putative Na+-binding site at the extracellular interface of N-lobe
and C-lobe in the MurJ-based inward-open homology mode of NorM-VC. a, D36 closely
interacts with N174 and N178 in the outward-open state. b, In the inward-open state, the D36
harbouring TMH1 rotates away from N174/N178 and approaches TMH8 which harbours two
amides, Q278 and N282 positioned at an equivalent position as N174 and N178 in TMH5.
This new arrangement of D36-Q278-N282 might allow the formation of a new Na+-binding
site at the interface between the N- and C-lobe in the inward-open conformation.
6.3 The amides Q278 and N282 are important for Na+-coupling
in NorM-VC
The possibility of a new Na+-binding site in the inward-facing state provides scope for the
Na+ bound at the N-lobe helices to be transferred to C-lobe helices. To test this hypothesis,
single point mutations were introduced to create NorM-VC Q278A and NorM-VC N282A.
These two mutants were successfully expressed in the plasma membrane of L. lactis and the
ethidium transport assay was used to test the effect of the mutations on the Na+ sensitivity of
NorM-VC.
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Fig. 6.5 Anti-His immunoblot showing the expression of NorM-VC WT, Q278A, and N282A
in the plasma membrane of L. lactis. 2 µg of total membrane protein was loaded onto each
lane. The non-expressing cells 8048 were used as negative control.
The activity of the amide (Q278 and N282) to alanine substitution mutants was tested
in ethidium transport assays in intact cells. As shown in Figure 6.6, the NorM-VC Q278A
mutant has similar activity as the wildtype, but the addition of 1 mM Na+ does not cause
stimulation of the ethidium export activity. The NorM-VC N282A mutant is less active
than the wild type - which might be due to lower expression levels. However, similar to the
Q278A mutant, the activity of N282A mutant is not stimulated by the addition of Na+. Thus,
both point mutations impair the stimulation of ethidium transport by Na+.
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Fig. 6.6 The NorM-VC Q278A and N282A mutants lose Na+-coupling, while still retaining
either full (Q278A) or diminished (N282A) ∆p-dependent ethidium export activity. NorM-VC
WT was used as positive control. The fluorescence traces shown on the left are representative
of 3 independent measurements, whereas the bar chart on the right shows mean values (±
SD) of the fluorescence end levels.
To further confirm the loss of Na+-binding to the NorM-VC Q278A and N282A mutants,
the proteins were purified in DDM-containing buffer solution. Ethidium binding to purified
mutant proteins was then measured in fluorescence anisotropy assays as described in the
previous chapters. The addition of 1 mM Na+ to the assay buffer did not cause any change in
the ethidium binding behaviour of these mutants. For NorM-VC Q278A mutant, the apparent
Kd values without and with Na+ were 0.19 ± 0.05 µM and 0.32 ± 0.07 µM, respectively. For
NorM-VC N282A mutant, the apparent Kd values without and with Na+ were 0.13 ± 0.02
µM and 0.08 ± 0.02 µM, respectively. This is different from the wildtype where addition of
Na+ leads to a 10-fold increased affinity of NorM-VC for ethidium (see Chapter 3, Fig. 3.7).
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Fig. 6.7 Purified NorM-VC single point mutants Q278A a, and N282A b, lose Na+-dependent
stimulation of ethidium binding. Elution buffer was used as control to generate the baseline
anisotropy. N=3 (independent studies).
The results shown above provide evidence for the involvement of residues Q278 and
N282 in Na+-binding and transport events in NorM-VC. Although, it is possible that the
phenotypes observed here might be due to indirect effects of the mutations, I propose that
these residues form a central Na+-binding site in the translocation pathway for Na+ that
connects the otherwise distant Na+-binding sites in the N- and C-lobes during the transition
from the outward-open to the inward-open state. In the next chapter, all these observations
are combined and a transport model, that explains the observations made on NorM-VC in
this thesis, is discussed.
Chapter 7
Discussion and future directions
Membrane transporters in the MATE family have significant physiological and clinical
relevance yet our current understanding of their structure-function relationship is very limited.
It cannot be emphasised enough that the key to understanding these transport systems might
be hidden between details and nuances. While it is very convenient to assume that two highly
homologues proteins have very similar structures and similar functionality, my studies on
NorM-VC and NorM-PS show that despite being very similar at the sequence level, these
two systems show major differences in energy coupling. NorM-PS strictly depends on H+
gradients and carries out a simpler H+/ethidium antiport reaction with no net transloction of
charge. In contrast, NorM-VC is more versatile in terms of its coupling-ion requirements
and can utilise either Na+ or H+ gradient or both simultaneously. This versatility makes the
dissection of the overall reaction more complex. Although the X-ray structure of NorM-VC
provides a good starting point, the questions regarding the binding sites for the drugs, H+,
and Na+ and their transport are essentially pertaining to dynamics in nature. For example,
in the crystal structure, the cation-binding site was seen in the C-lobe of NorM-VC but
the chimeric proteins characterised in this thesis indicate that the transport must involve a
pathway composed of a sequence of sites in both the N-lobe and C-lobe. Also, it is very
important to understand how these binding events affect each other and in what order they
take place.
7.1 A novel transport model for NorM-VC
Based on the observations made in this thesis, a transport model is presented here. This
model incorporates H+, Na+, and substrate binding and dissociation in the transport cycle.
The following steps describe the events as they might take place per transport cycle:
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Step 1 Binding of a proton and switch to the inward-open conformation: The Na+
binds at the D36 region, coordinated by D36, N174, and N178 (perhaps also by T200 [66]).
The binding of a H+ at the E255TMH7/D371TMH10-dyad makes the carboxylate groups of
these two residues come closer and form a H-bond, which leads to introduction of a kink
at G245 (GFP motif in TMH7). This event is similar to the TMH7 bending in plant MATE
AtDTX14, and is also analogous with the helix-bending event in pfMATE [36] where P26
and G30 in TMH1 form a flexible switch that can introduce a helix kink at acidic pH. The
bending of TMH7 in NorM-VC causes a dramatic conformational switch to the inward-open
state. Based on the currently available data, it is difficult to say whether the binding of the
two coupling-ions (Na+ and H+) is ordered, and if so, which ion will bind first. If the crystal
structure of outward-facing NorM-VC is taken as the initial conformation in the transport
cycle, then a simple cavity analysis can provide a clue which of the two ions has easier
accessibility to its binding site. To look for cavities in NorM-VC structure, the online server
CastP 3.0 [67] was used. A probe of radius 1.4 Å (radius of the water molecule) was used
to search for cavities. The results provided by CastP 3.0 include the cavity volume, area,
number of openings and the exposed residues. NorM-VC appears to have numerous cavities
of which only two are near D36 and N174 (the first binding site for Na+ from the extracellular
side). Both cavities, occluded by surrounding helices, lack openings and are inaccessible to
Na+.
Fig. 7.1 Cavity surface of NorM-VC crystal structure (PDB ID: 3MKU). a, Of all the cavities
formed in NorM-VC, only two occluded cavities are formed near D36 and N174. b, the
cavities close to D36 and N174 are small in volume ( 153 Å, each) and have no openings.
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On the other hand, the H+-binding site formed by E255/D371 is accessible via the biggest
cavity in the outward-open conformation. This cavity is open to the extracellular environment
and hence a proton (H3O+) could directly approach the E255/D371-dyad from the outside. It
is therefore possible that the binding of H+ is the precondition for Na+-binding to NorM-VC.
Fig. 7.2 a, in NorM-VC (PDB ID: 3MKU),a large cavity with four openings exposes E255
and D371 to the external aqueous environment.a, the cavity as seen from the top. b, Close-up
view showing these two residues exposed to the cavity.
Step 2 The intermediate/transition state with Na+-binding at the extracellular in-
terface: The inward-open state brings the extracellular sides of the N-lobe and C-lobe
together. A novel higher affinity Na+-binding site is formed involving TMH1 (D36) and
TMH8 (Q278 and N282). The semi-parallel structure of DinF-BH (PDB ID: 4LZ6) shows
similarly proximally spaced extracellular sides of TMH1 and TMH8 too. Na+ binds at
this newly formed binding-site on its way from the D36 centre in the N-lobe to the final
binding-site at the E255-D371 centre in the C-lobe.
Step 3 Release of H+ and substrate binding: The switch from the outward-open state to
the inward-open state exposes E255 to the alkaline interior. The H+ that was shared by E255
and E371 dissociates and is replaced by the incoming Na+ from the D36-Q278-N282 site. H+-
release and Na+-binding create a high-affinity binding site for the drug molecule (ethidium).
Previously, molecular dynamics simulations suggested that in order for Na+ to bind, D371
should be protonated and E255 should be deprotonated [39]. Yet, experimentally it has been
shown that deprotonation at D371 leads to ethidium binding. Na+- and ethidium-binding
events must overlap temporally for Na+ to promote ethidium-binding to NorM-VC. Hence
it can be deduced that H+-release coincides with Na+ and ethidium-binding as observed in
biochemical experiments [34].
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Fig. 7.3 A cartoon representation of the proposed NorM-VC transport model. Red
ball=sodium ion, blue ball=proton, numbered cylinders represent transmembrane helices and
the amino acid residues taking part in transport cycle are numbered.
Step 4 The substrate and Na+ are released and the initial conformation is restored:
H+-release causes the transporter to switch back to the outward-open state which has lower
affinity for the bound substrate and Na+. The substrate is released into the exterior whereas
Na+ is released into the cellular interior, and the transporter assumes the original conformation
– ready to undergo another transport cycle.
This model explains most of the empirical observation for NorM-VC and places all the
players (H+, Na+ and drug molecule) together from a functional perspective. Based on this
model, the positive cooperation between Na+ and ethidium binding and the competition
between H+ and ethidium binding can be explained. The cooperativity between the N- and
C-lobes for Na+-binding explains why the NorM-VC and NorM-PS chimeras (discussed in
Chapter 3) do not show Na+-dependent stimulation of the ethidium transport activity.
The stoichiometry of 1 Na+-1 H+-/ethidium+- antiport in the model suggests the existence
of three driving forces for ethidium transport by NorM-VC from cells: (i) ∆pH (interior
alkaline), (ii) ∆ψ (interior negative), and (iii) the chemical concentration gradient of ethidium
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(∆pEthidium, interior high). Under physiological conditions during normal drug efflux with
low interior ethidium concentration, the ∆pEthidium will actually be inhibitory for drug efflux.
With an established apparent Kd for Na+ of 4.7±0.6 µM [34] , the affinity of NorM-VC for
Na+ is so high that the contamination of Na+ in cell suspensions will be sufficient to support
transport even when the ion is not added to my biochemical buffers. In my experiments in
Chapters 3 and 4, the ethidium efflux reaction in cells was found to be dependent on the
∆pH plus ∆ψ at pH 7 and 8. Addition of Na+ to the buffer, thus creating a ∆pNa (interior
low), further stimulated ethidium efflux. Under conditions where the ∆pH prevails in cells
(pH 6), the efflux reaction showed a bias towards the ∆pH. The lack of coupling to the ∆ψ
in the presence of the ionophore nigericin at pH 6.0 might be a consequence of the very
low internal pH (pHin = pHout under these conditions, which is inhibitory for NorM-VC
and other membrane transporters. Following the initial and ground-breaking studies on the
lactose-proton symporter LacY [68], it is generally assumed that secondary-active membrane
transporters are molecular machines that operate with a fixed ion coupling stoichiometry
under all environmental conditions. It is the differences in the availability of driving forces
under the various experimental conditions that creates an experimental bias towards one
driving force over another. Most of my data can be explained if the stoichiometry of NorM-
VC is fixed at 1 Na+-1 H+/ethidium+ antiport. However, the possibility still exists that
NorM-VC contains promiscuous ion binding sites that can interact with Na+ and/or H+ in a
fashion that depends on their availability. The existence of promiscuous Na+/H+ binding sites
has been studied in other membrane proteins before [62]. In this scenario, it is conceivable
that at higher pH values the ratio of Na+ over H+ changes and more Na+ is transported than
H+. In other words, the H+ binding sites in NorM-VC would act as Na+ binding sites at basic
pH.
Although all the key residues relevant for this model are conserved in NorM-PS, it can be
reasoned that there are additional structural features, such as helical rotations or main-chain
interactions that allow NorM-VC to transport Na+ and are not available in NorM-PS.
In support of this model, molecular dynamics simulations have suggested that Na+-
binding in NorM-NG involves D41 (D36NorM-VC), D52, D355, and D356, before Na+ finally
moves to the cation-binding site at E261 (E255NorM-VC) [69]. Also, the same study reported
that a D41A mutation completely abolishes the binding of the Na+ - a finding consistent
with the experimental data on NorM-VC D36N in this thesis. During the final stages of
the research presented here, a new EPR spectroscopy study provided information on the
conformational changes occurring in NorM-VC upon binding of H+ and Na+ [66]. The
distance measurements show that Na+-binding and substrate-binding stabilise two mutually
exclusive states (outward-open and inward-open, respectively). But the results with ethidium
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anisotropy results in Chapter 4, along with the ethidium-monoazide binding studies [34]
and the EPR studies on Ruboxyl binding to NorM-VC [43], clearly show that Na+ and
substrate binding to NorM-VC are not mutually exclusive, in fact, the presence of Na+
promotes the binding of ethidium to NorM-VC. This observation is also consistent with the
non-overlapping binding-sites for Cs+ and TPP in NorM-NG.
The H+- and Na+-coupled drug transport model presented here has the potential to be
applicable to other MATE transporters. As discussed in Chapter 1, MATE transporters have
a conserved sequence motifs (the GXP motif in TMH-7) and carboxyl residues. The model
allocates functional relevance to these structural features. For example, the human MATE
transporter, hMATE1 might function by the same carboxylate-dyad protonation and TMH7-
bending mechanism. It is possible that in absence of a D36NorM-VC equivalent carboxylate,
hMATE1 functions as a H+/drug+ antiporter. This antiport reaction might be analogues to
the electroneutral antiport carried out by the NorM-VC D36N mutant.
The DinF-family MATE transporters achieve a similar mechanism by forming a car-
boxylate dyad in the N-lobe and the ‘structural spur’ comes from the bending of TMH1,
a feature that accentuates the existence of two-fold structural and functional symmetry in
MATE transporters. The transport-active chimeric MATE proteins discussed in Chapter 3
also point towards a functional symmetry between the N- and C-lobes in MATE transporters.
The results presented in this thesis also provide insights into the ecological relevance
of the ion-coupling versatility exhibited by NorM-VC. As discussed in Chapter 4, under
alkaline conditions, the ∆p-independent, Na+-coupled ethidium transport by NorM-VC
indicates toward an adaptive feature in NorM-VC that might enable Vibrio cholera to thrive
in constantly fluctuating pH and saline conditions in the estuaries where this bacterium
resides.
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7.2 Future research directions
The following section contain a brief account of the potential studies that can be carried out to
better probe the transport cycle and overall structural dynamics in NorM-VC and NorM-PS.
1. To determine of the protonation states of the catalytic carboxylates in NorM pro-
teins: The protonation of carboxylate residues in membrane proteins has been studied before
and one of the successful approaches is the dicyclohexylcarbodiimide (DCCD) labelling of
the proteins [70]. DCCD reacts with protonated (especially membrane-buried) carboxylates
and the label can be detected by means of mass-spectrometric techniques. DCCD treatment
was shown to inhibit the facilitated influx of ethidium by NorM-VC (reverse transport) in
deenergised L. lactis cells (Figure 7.4). However, due to incomplete digestion of the purified
DCCD-labelled protein, the mass spectrometric coverage was poor and identification of the
labelled carboxylate(s) was inconclusive. Cyanogen bromide (CNBr) has been found to be
more effective at cleavage of membrane proteins and hence the experiments can be repeated
with CNBr cleavage of DCCD labelled NorM-VC (or NorM-PS). Since NorM-PS has the
same catalytic carboxylates as NorM-VC but only antiports one H+ per cycle, it will be
interesting to know which of the three carboxylates (D38, E257, and D373) has catalytic
importance in proton coupling. DCCD labelling could be used for this purpose. The effect of
single, double, and triple carboxylate substitutions (NorM-PS D38N, E257N and D373N)
on ethidium transport activity of NorM-PS expressing L. lactis cells was tested by me; the
preliminary results require further repeats. In a previous study, substitution of any of these
three carboxylates by amides led to disruption of the DAPI/H+ antiport activity by mutant
proteins [42]. In the same study E257 and D373 were found to be important for substrate
binding and D38 was stated to be involved in H+-coupling, which is not analogous with their
counterpart residues in NorM-VC.
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Fig. 7.4 DCCD reacts with NorM-VC and inhibits proton-coupled NorM-VC mediated influx
of ethidium in deenergized cells in a dose-dependent a, and time dependent b, manner.
NorM-VC expressing L. lactis cells were incubated with varying concentrations of DCCD,
after which 2 µM ethidium bromide was added to the buffer. The ethidium accumulation
rate in the linear phase was then determined and normalised against the rate of influx in the
no-DCCD control.
2. To probe the structural switch in NorM transporters: Different opinions exist
in the published literature on whether all MATE transporters function by the same con-
formational switch as that of pfMATE (protonation-driven helix bending) or not. MATE
transporters appear to conserve a G(X)nP motif in helices that harbour catalytic carboxylates.
Interestingly, upon comparing the crystal structure of outward-facing NorM-VC with our
MurJ-based homology model of the inward-open state, a significant torsional difference is
seen at the Gly245 (part of the GXP motif in NorM-VC) site of the TMH7 (phi value changes
by 78 degrees). In order to assess the importance of this GXP motif in NorM transporters,
the effect of bulkier amino acid substitutions in this motif can be tested in drug transport and
binding assays. If it is indeed the bending of the TMH7 that exposes the drug binding site
in the transporter, rendering the helix inflexible (by introducing bulkier side-groups) should
cause disruption of drug binding and transport. Also, the disruption of the conformational
switch can be tested by distance measurements between amino acid positions using EPR
techniques.
3. To explore the (pseudo) two-fold symmetry in NorM proteins: As discussed
in Chapter 1, MATE transporters are suspected to function by an alternative two-state
mechanism that relies on the symmetry between the two lobes. As was shown in Chapter
3, chimeras generated by swapping the N- and C-lobes of NorM-VC and NorM-PS were
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found to be transport-active proteins. This further strengthens the notion of a two-fold
symmetry-based mode of operation in MATE transporters. One way to test this hypothesis
could be to examine whether a protein composed of two N-lobes or two C-lobes is transport
active. Also, such proteins can be used to study whether or not the binding-sites for substrates
and ions fully reside in one of the two domains or whether they utilise both domains in a
sequential fashion and/or bind at the interface between the domains.
4. To study the pH-dependence of Na+-mediated stimulation of ethidium transport
activity of NorM-VC: The studies of the effects of the proton availability on the ion-
coupling in NorM-VC, as described in Chapter 4, could potentially be extended to NorM-
VC incorporated in proteoliposomes . The effect of H+ availability on the Na+-dependent
stimulation of ethidium efflux to NorM-VC can be studied to explore the relationship between
H+ versus Na+ availability and transport. Previously, NorM-VC reconstituted in liposomes
was shown to couple ethidium transport to ∆pNa under mildly acidic conditions (internal
buffer pH= 6.8) [34]. In these experiements, NorM-VC was reconstituted in inside-out
orientation and the extracellular side of the protein, which contains D36, faced acidic buffer.
To further corroborate the findings in this thesis, NorM-VC can be reconstituted in liposomes
prepared with internal buffer containing a fixed concentration of Na+. If Na+-dependent
stimulation of ethidium transport is truly pH-dependent then more ethidium should be
transported in liposomes with alkaline internal buffer than in liposomes with acidic internal
buffer.
Fig. 7.5 Ethidium transport by NorM-VC reconstituted in liposomes loaded with DNA. In
these experiments, the external buffer can be changed to test the effect of various factors
on transport. Previously, reconstituted NorM-VC was shown to utilise Na+ to transport
ethidium while the extracellular side of the protein faced low pH buffer, a condition similar
to a. In order to test the stimulation of Na+-driven ethidium transport by NorM-VC, the same
experiment can be done at alkaline pHs, a condition similar to b.
94 Discussion and future directions
The relationship between H+ and Na+ binding to NorM-VC can also be studied using
ethidium binding as a reporter in fluorescence anisotropy experiments. The measurements
presented in this thesis show that the addition of Na+ leads to enhanced binding of ethidium
to purified NorM-VC. However, it is not yet known how this phenomenon is affected by
pH. In experiments, the binding of ethidium to NorM-VC could be measured at a fixed
Na+ concentration and a range of pH values. These and other studies would increase our
understanding of how H+ and Na+ interact with NorM-VC.
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1. ABC: ATP binding cassette
2. ADP: Adenosine diphosphate
3. ANOVA: Analysis of variation
4. ATP: Adenosine triphosphate
5. BSA: Bovine serum albumin




10. DiOC2(3): 3,3’-Diethyloxacarbocyanine Iodide
11. DNP: 2,4-dinitrophenol
12. DNA: Deoxyribonucleic acid
13. DTT: Dithiothreitol
14. EPR: Electron paramagnetic resonance
15. HRP: Horse radish peroxidase
16. IgG: Immunoglobulin G
104 Abbreviations and symbols
17. ISOV: Inside-out vesicles:
18. K-EDTA: Potassium-Ethylene diamine tetraacetate
19. LB: Lysogeny broth
20. MATE: Multidrug and toxic compound extrusion
21. MDT: Multidrug transporters
22. MOP: Multidrug/oligosaccharidyl-lipid/polysaccharide
23. ODx: optical density at wavelength x nm
24. Pi: Phosphate group
25. PMF: Proton motive force
26. Kpi: Potassium phosphate group
27. norM-PS: NorM gene from Pseudomonas stutzeri
28. norM-VC: NorM gene from Vibrio Cholerae
29. NorM-PS: NorM protein from Pseudomonas stutzeri
30. NorM-VC: NorM protein from Vibrio Cholerae
31. SCOP: Strcutural classification of proteins
32. SD: Standard deviation
33. SDS-PAGE: Sodium dodecyl sulphate-polyacrylamide gel electrophoresis
34. PCR: Polymerase chain reaction
35. PDB: Protein data bank
36. PNK: Polynucleotide kinase
37. RPM: Rotations per minute
38. RTH: Round-the-horn
39. TBST: Tris buffered saline-Tween 20
40. TMH: Transmembrane helix
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41. UV: Ultraviolet
42. ∆p: Proton motive force
43. ∆pH: pH gradient across membrane
44. ∆pNa: Na+ gradient across membrane
45. ∆ψ: Transmembrane potential

